{ "company": "Thermo Fisher Scientific", "ticker": "TMO", "period": { "from": "2026-03-27", "to": "2026-04-26", "days": 30 }, "sentiment_breakdown": { "positive": 81, "negative": 41, "neutral": 79 }, "synthesis": { "executive_summary": "Sentiment analysis for Thermo Fisher Scientific (TMO) from 2026-03-27 to 2026-04-26. Analyzed 201 items across FDA and news sources.", "key_findings": [], "overall_sentiment": "neutral" }, "top_positive": [ { "title": "AI-Powered Clinical Trial Site Feasibility Research Report 2026: $4.38 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F", "date": "2026-04-24", "source": "news", "score": 1.0 }, { "title": "NGS Kits Market Forecasted to Skyrocket from USD 1.1 Billion to USD 11.5 Billion by 2035: Hospitals and Clinics Expected to Capture 45% Share", "date": "2026-04-23", "source": "news", "score": 1.0 }, { "title": "Cell Free Expression Industry Set to Reach USD 627 Million by 2035 - Investment in Cell Free Systems Surpasses USD 8 Billion in Last Six Years", "date": "2026-04-20", "source": "news", "score": 0.962 }, { "title": "Cardiff beat Ospreys to improve URC play-off hopes", "date": "2026-04-24", "source": "news", "score": 0.944 }, { "title": "Cardiff beat Ospreys to improve URC play-off hopes", "date": "2026-04-24", "source": "news", "score": 0.944 }, { "title": "Cardiff stun Scarlets with late URC fightback", "date": "2026-04-18", "source": "news", "score": 0.931 }, { "title": "Cardiff stun Scarlets with late URC fightback", "date": "2026-04-18", "source": "news", "score": 0.931 }, { "title": "Single Use Bioprocessing Markets and Competition Insights Report 2026 - Industry Set to Triple in Value by 2035, Reaching USD 15.5 Billion", "date": "2026-04-20", "source": "news", "score": 0.914 }, { "title": "Connacht comeback stuns Stormers in Cape Town", "date": "2026-04-18", "source": "news", "score": 0.91 }, { "title": "Connacht comeback stuns Stormers in Cape Town", "date": "2026-04-18", "source": "news", "score": 0.91 } ], "top_negative": [ { "title": "Electrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerability", "date": "2026-04-24", "source": "news", "score": -0.823 }, { "title": "Focal white matter lesions drive grey matter inflammation and synapse loss", "date": "2026-04-22", "source": "news", "score": -0.799 }, { "title": "Antitumoral immunity induced by gel ethanol ablation to treat unresectable colorectal cancer metastases in the liver", "date": "2026-04-22", "source": "news", "score": -0.796 }, { "title": "Reappraisal of profibrotic phenotype and cell-cycle state of renal tubular epithelium after ischemia–reperfusion injury", "date": "2026-04-24", "source": "news", "score": -0.784 }, { "title": "Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer", "date": "2026-04-22", "source": "news", "score": -0.727 }, { "title": "Impact of tumor location on the efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.", "date": "2026 Apr 9", "source": "pubmed", "score": -0.718 }, { "title": "Entry, replication and innate immunity evasion of BANAL-236, a SARS-CoV-2-related bat virus, in Rhinolophus and human cells", "date": "2026-04-20", "source": "news", "score": -0.7 }, { "title": "Emerging Sub-Segments Transforming the Thyroid Cancer Diagnostics Market Landscape", "date": "2026-04-24", "source": "alpha_vantage", "score": -0.66 }, { "title": "Immune-related gene expression profiling and alectinib efficacy for patients with ALK-Rearranged non-small cell lung cancer: exploratory analysis of a prospective observational study.", "date": "2026 Apr 1", "source": "pubmed", "score": -0.66 }, { "title": "Structure of the human P2X3 receptor reveals the basis for subtype-selective inhibition by sivopixant", "date": "2026-04-22", "source": "news", "score": -0.637 } ], "raw_data": { "total_items": 201, "items": [ { "source": "sec", "filing_type": "8-K", "title": "8-K - Current report", "date": "2026-04-23", "url": "https://www.sec.gov/Archives/edgar/data/97745/000009774526000086/0000097745-26-000086-index.htm", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Advisors Capital Management LLC Has $37.48 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO", "url": "https://www.marketbeat.com/instant-alerts/filing-advisors-capital-management-llc-has-3748-million-stock-holdings-in-thermo-fisher-scientific-inc-tmo-2026-04-26/", "date": "2026-04-26", "summary": "MarketBeat reports that Advisors Capital Management LLC significantly reduced its stake in Thermo Fisher Scientific Inc. ($TMO) by 44.5% in the fourth quarter, valuing their remaining holdings at $37.48 million. Despite this, several other institutional investors, including Vanguard Group Inc. and Munich Reinsurance Co Stock Corp, increased their positions. The article also provides financial performance data, details of a dividend increase, market sentiment, and recent insider trading activitie", "sentiment_score": 0.028479, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc. $TMO Shares Purchased by Munich Reinsurance Co Stock Corp in Munich", "url": "https://www.marketbeat.com/instant-alerts/filing-thermo-fisher-scientific-inc-tmo-shares-purchased-by-munich-reinsurance-co-stock-corp-in-munich-2026-04-25/", "date": "2026-04-25", "summary": "Munich Reinsurance Co Stock Corp in Munich significantly increased its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 60.1% in the fourth quarter, acquiring an additional 23,375 shares, bringing their total to 62,250 shares valued at $36.32 million. Other institutional investors also adjusted their positions in TMO, while the company reported strong Q1 earnings, beating EPS and revenue expectations, and raised its full-year guidance for 2026. Despite positive financial results and analy", "sentiment_score": 0.089592, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Calamos Advisors LLC Raises Stake in Thermo Fisher Scientific Inc. $TMO", "url": "https://www.marketbeat.com/instant-alerts/filing-calamos-advisors-llc-raises-stake-in-thermo-fisher-scientific-inc-tmo-2026-04-25/", "date": "2026-04-25", "summary": "Calamos Advisors LLC increased its stake in Thermo Fisher Scientific Inc. by 15% in the fourth quarter of the prior year, bringing its total holdings to 169,900 shares valued at approximately $98.45 million. Thermo Fisher Scientific recently reported strong Q1 results, beating analyst expectations for EPS and revenue, and raising its FY2026 EPS guidance. The company also increased its quarterly dividend to $0.47 per share, while analysts maintain a \"Moderate Buy\" rating with an average price tar", "sentiment_score": 0.248909, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher sees higher Q1 earnings amid strong biopharma demand", "url": "https://www.fiercebiotech.com/medtech/thermo-fisher-sees-higher-q1-earnings-amid-strong-biopharma-demand", "date": "2026-04-25", "summary": "Thermo Fisher Scientific reported a strong first quarter, with revenues up 6% to $11.01 billion and adjusted earnings per share increasing by 6% to $5.44, driven by strong biopharma demand and investment in new technologies. The company also completed its $9 billion acquisition of Clario and raised its 2026 revenue and adjusted EPS guidance, with CEO Marc Casper highlighting AI as a significant long-term growth opportunity despite modest inflationary pressures.", "sentiment_score": 0.801167, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.421, "confidence": 0.42 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Raises Outlook As Clario Deal Deepens AI Trial Capabilities", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/thermo-fisher-raises-outlook-as-clario-deal-deepens-ai-trial", "date": "2026-04-25", "summary": "Thermo Fisher Scientific has acquired clinical trial technology provider Clario, leading to a raised full-year revenue and EPS guidance. This acquisition integrates AI-driven clinical research capabilities, enhancing Thermo Fisher's offerings in trial efficiency and data quality. The company aims to leverage Clario's platform to strengthen its position in the competitive clinical research market, while analysts note potential risks related to debt and integration challenges.", "sentiment_score": 0.457339, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Is Danaher’s (DHR) Euro Debt for Masimo a Smart Balance-Sheet Bet or Added Complexity?", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/news/is-danahers-dhr-euro-debt-for-masimo-a-smart-balance-sheet-b", "date": "2026-04-25", "summary": "Danaher Corporation recently priced a €2.98 billion euro-denominated senior notes offering to fund its acquisition of Masimo Corporation and for general corporate uses. This move links Danaher's balance sheet to its Masimo ambitions, occurring alongside strong first-quarter earnings and increased full-year adjusted EPS guidance. The article explores how this financing, combined with current profitability and a larger medical technology footprint, influences Danaher’s investment narrative while a", "sentiment_score": 0.140711, "sentiment_label": "Neutral", "relevance_score": 0.614444, "sentiment": { "label": "positive", "score": 0.052, "confidence": 0.05 } }, { "source": "alpha_vantage", "title": "Stryker Corp. Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics", "url": "https://www.marketsmojo.com/news/stocks-in-action/stryker-corp-sees-valuation-grade-change-from-expensive-to-fair-amid-stock-decline-3961481", "date": "2026-04-24", "summary": "Stryker Corp. has adjusted its stock valuation to $329.65, experiencing a -7.69% stock return over the past year, in contrast to the S&P 500's 32.23% return. Despite solid operational performance indicated by a P/E ratio of 33 and ROCE of 17.16%, the company faces competitive pressures within the Pharmaceuticals & Biotechnology sector. Its valuation metrics are mixed compared to peers, with some competitors showing more attractive or higher valuations.", "sentiment_score": 0.227492, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.628726, "sentiment": { "label": "positive", "score": 0.421, "confidence": 0.42 } }, { "source": "alpha_vantage", "title": "Thermo Fisher dips in premarket despite Q1 earnings beat", "url": "https://www.msn.com/en-us/money/other/thermo-fisher-dips-in-premarket-despite-q1-earnings-beat/ar-AA21yM9C", "date": "2026-04-24", "summary": "The provided article content is empty. Therefore, a summary cannot be generated.", "sentiment_score": -0.41303, "sentiment_label": "Bearish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Medicinal Microbiology Market Is Going to Boom | Major Giants bioMérieux SA, Hologic, Cepheid", "url": "https://www.openpr.com/news/4487746/medicinal-microbiology-market-is-going-to-boom-major-giants", "date": "2026-04-24", "summary": "The global Medicinal Microbiology Market is projected to reach USD 5 billion by 2033, growing at a CAGR of 6.2% from its current USD 3.3 billion valuation, driven by increasing infectious disease burdens and technological advancements in diagnostics. Key players include Thermo Fisher Scientific, Roche Diagnostics, and bioMérieux SA. The market is propelled by trends such as molecular diagnostics, automation, and point-of-care testing, with significant opportunities in personalized medicine and e", "sentiment_score": 0.436579, "sentiment_label": "Bullish", "relevance_score": 0.937859, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Leerink Partners Adjusts Price Target on Thermo Fisher Scientific to $600 From $650, Maintains Outperform Rating", "url": "https://www.marketscreener.com/news/leerink-partners-adjusts-price-target-on-thermo-fisher-scientific-to-600-from-650-maintains-outpe-ce7f59dfdc8ff525", "date": "2026-04-24", "summary": "Leerink Partners has lowered its price target for Thermo Fisher Scientific (TMO) to $600 from $650, while maintaining an Outperform rating on the stock. This adjustment comes amidst similar moves by other financial institutions like Stifel, JPMorgan, Baird, Goldman Sachs, and Jefferies, all revising their price targets for the company recently, mostly downwards. Thermo Fisher Scientific specializes in laboratory and scientific equipment, analysis equipment, and diagnostics.", "sentiment_score": 0.042216, "sentiment_label": "Neutral", "relevance_score": 0.313916, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "JPMorgan Adjusts Price Target on Thermo Fisher Scientific to $600 From $710, Maintains Overweight Rating", "url": "https://www.marketscreener.com/news/jpmorgan-adjusts-price-target-on-thermo-fisher-scientific-to-600-from-710-maintains-overweight-ra-ce7f59dfdc8ff622", "date": "2026-04-24", "summary": "JPMorgan has revised its price target for Thermo Fisher Scientific (TMO) to $600 from $710, while maintaining an Overweight rating on the stock. This adjustment comes amidst a broader reconsideration of analyst ratings for the company, as several other firms have also recently updated their price targets. Thermo Fisher Scientific specializes in laboratory and scientific equipment, with its net sales predominantly from laboratory equipment, scientific analysis equipment, and diagnostics.", "sentiment_score": -0.250229, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.361, "confidence": 0.36 } }, { "source": "alpha_vantage", "title": "Human Microbiome Sequencing Technology Market Competitive Analysis to 2034 | Thermo Fisher Scientific Inc., QIAGEN N.V., Microbiome Insights Inc., Leucine Rich Bio Pvt. Ltd., Illumina, Inc etc.", "url": "https://www.openpr.com/news/4487512/human-microbiome-sequencing-technology-market-competitive", "date": "2026-04-24", "summary": "The global Human Microbiome Sequencing Technology market is projected to grow from US$ 2.19 billion in 2025 to US$ 4.92 billion by 2034, driven by increasing awareness of the microbiome's role in health, rising chronic diseases, and advancements in sequencing technologies like Next Generation and Third Generation Sequencing. North America currently leads the market, but Asia Pacific is expected to see the fastest growth. Key players include Thermo Fisher Scientific Inc., QIAGEN N.V., and Illumin", "sentiment_score": 0.42738, "sentiment_label": "Bullish", "relevance_score": 0.913931, "sentiment": { "label": "positive", "score": 0.649, "confidence": 0.65 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc. (NYSE:TMO) Q1 2026 Earnings Call Transcript", "url": "https://www.insidermonkey.com/blog/thermo-fisher-scientific-inc-nysetmo-q1-2026-earnings-call-transcript-1745746/", "date": "2026-04-24", "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) reported a strong start to 2026, beating Q1 earnings expectations with an EPS of $5.44 against an expected $5.25. The company raised its full-year revenue and adjusted EPS guidance, attributing the positive outlook to robust operational performance, the successful acquisition of Clario, and solid growth in its pharma and biotech end markets, particularly in bioproduction and clinical research. Management expressed confidence in its growth strategy, high-i", "sentiment_score": 0.521265, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Does Agilent (A) Settling Axion Dispute Clarify Its Push Into Cloud Lab Data Recurring Revenues?", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/does-agilent-a-settling-axion-dispute-clarify-its-push-into", "date": "2026-04-24", "summary": "Agilent Technologies recently settled a confidential dispute with Axion BioSystems, which, while immaterial to near-term financials, removes a legal overhang. This resolution aligns with Agilent's strategy to expand its recurring software and data-management revenues in the growing Cloud Electronic Laboratory Notebook market. The company aims to offset tariff pressures and capital spending cyclicality through higher-margin software solutions.", "sentiment_score": 0.135587, "sentiment_label": "Neutral", "relevance_score": 0.614764, "sentiment": { "label": "negative", "score": -0.402, "confidence": 0.4 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc. $TMO is Davis Rea LTD.'s 6th Largest Position", "url": "https://www.marketbeat.com/instant-alerts/filing-thermo-fisher-scientific-inc-tmo-is-davis-rea-ltds-6th-largest-position-2026-04-24/", "date": "2026-04-24", "summary": "Davis Rea LTD. significantly reduced its stake in Thermo Fisher Scientific Inc. (TMO) by 28.5% in Q4 2025, yet TMO remains its 6th largest holding. Despite beating Q1 earnings estimates and raising FY2026 guidance, the stock experienced a dip due to softer organic growth and mixed segment performance. Institutional investors own about 89% of TMO, even as company insiders sold shares, though Thermo Fisher also increased its quarterly dividend.", "sentiment_score": 0.066397, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Emerging Sub-Segments Transforming the Thyroid Cancer Diagnostics Market Landscape", "url": "https://www.openpr.com/news/4486762/emerging-sub-segments-transforming-the-thyroid-cancer", "date": "2026-04-24", "summary": "The thyroid cancer diagnostics market is projected to reach $4.25 billion by 2030, growing at a CAGR of 6.2%, driven by technological advancements and demand for precise detection. Key trends include AI-assisted imaging, personalized oncology diagnostics, and expanded molecular testing. Major companies like General Electric and F. Hoffmann-La Roche AG are leading innovations, with market segmentation covering various technique types, disease types, and end-users.", "sentiment_score": 0.422322, "sentiment_label": "Bullish", "relevance_score": 0.830287, "sentiment": { "label": "negative", "score": -0.66, "confidence": 0.66 } }, { "source": "alpha_vantage", "title": "Cytomegalovirus (CMV) Infection Pipeline Set for Strategic Expansion Through 2026 with 20+ Therapies and Robust Innovation from ModernaTX, Helocyte, VBI Vaccines, and GSK | DelveInsight", "url": "https://www.barchart.com/story/news/1490725/cytomegalovirus-cmv-infection-pipeline-set-for-strategic-expansion-through-2026-with-20-therapies-and-robust-innovation-from-modernatx-helocyte-vbi-vaccines-and-gsk-delveinsight", "date": "2026-04-24", "summary": "The Cytomegalovirus (CMV) infection pipeline is poised for significant expansion through 2026, with over 20 therapeutic candidates from companies like ModernaTX, Helocyte, VBI Vaccines, and GSK driving innovation. The focus is shifting towards next-generation vaccines, antiviral innovations, and immune-targeted strategies to address this persistent viral threat, especially for immunocompromised individuals and congenital CMV. Key developments include mRNA-based platforms, viral vector technologi", "sentiment_score": 0.20156, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.564822, "sentiment": { "label": "positive", "score": 0.812, "confidence": 0.81 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific (TMO) Margin Hold At 15% Tests Long Term Earnings Concerns", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/thermo-fisher-scientific-tmo-margin-hold-at-15-tests-long-te", "date": "2026-04-24", "summary": "Thermo Fisher Scientific (TMO) reported Q4 2025 revenue of US$12.2 billion and basic EPS of US$5.22, with trailing twelve-month revenue at US$44.6 billion and a net margin of 15%. While recent profitability improved with 5.8% earnings growth, this stands against a five-year earnings decline of 6.1% annually, raising concerns about long-term growth and debt coverage despite a P/E ratio below the industry average. The company's current valuation and forecasts present a mixed picture for investors ", "sentiment_score": 0.109387, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Rapport Therapeutics (RAPP) outlines 2026 vote, board structure and executive pay", "url": "https://www.stocktitan.net/sec-filings/RAPP/def-14a-rapport-therapeutics-inc-definitive-proxy-statement-c553bddea5a9.html", "date": "2026-04-24", "summary": "Rapport Therapeutics (RAPP) has released details concerning its 2026 annual meeting, board structure, and executive compensation. Stockholders will vote on electing three Class II directors and ratifying PricewaterhouseCoopers LLP as the independent auditor. The proxy statement also provides comprehensive information on executive pay, including CEO Abraham Ceesay's total compensation of over $6.2 million in 2025, and outlines the company's governance policies, including those for insider trading", "sentiment_score": 0.128176, "sentiment_label": "Neutral", "relevance_score": 0.619613, "sentiment": { "label": "negative", "score": -0.103, "confidence": 0.1 } }, { "source": "alpha_vantage", "title": "How Thermo Fisher built FluidEase Pro, its first touchscreen pipette, over 2.5 years and 20 software revisions", "url": "https://www.rdworldonline.com/how-thermo-fisher-built-fluidease-pro-its-first-touchscreen-pipette-over-2-5-years-and-20-software-revisions/", "date": "2026-04-23", "summary": "Thermo Fisher Scientific developed the FluidEase Pro ClipTip, its first handheld pipette with a large touchscreen, over 2.5 years and 20 software revisions. The device features a 2-inch IPS LCD touchscreen, Bluetooth 5.0 connectivity, multiple user profiles, and electronic tip ejection, aiming to improve lab efficiency and reduce repetitive strain injuries. Customer feedback significantly influenced its design, including a rotating finger rest to accommodate different users.", "sentiment_score": 0.422462, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Organic Revenue Flat, Stock Price Drops for Thermo Fisher Scientific", "url": "https://www.wfmz.com/business/organic-revenue-flat-stock-price-drops-for-thermo-fisher-scientific/article_19b8df47-3194-48c7-a7c4-c5c689ba413e.html", "date": "2026-04-23", "summary": "Thermo Fisher Scientific experienced an unusual stock drop of over 10% despite reporting better-than-expected first-quarter sales and profit results. Analysts are concerned about the company's long-term prospects due to organic revenue growth of only 1.6% over the past two years and a steady decline in adjusted operating margin over five years. Despite these concerns, analysts still consider Thermo Fisher to be a strong company in the healthcare sector.", "sentiment_score": -0.21537, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Danaher’s €3b Euro Debt Issue And What It Means For Valuation", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/news/danahers-3b-euro-debt-issue-and-what-it-means-for-valuation", "date": "2026-04-23", "summary": "Danaher (NYSE:DHR) has launched a significant €3 billion euro-denominated debt offering through senior notes to fund its pending acquisition of Masimo Corporation. This move introduces a new component to Danaher's capital structure, and investors should monitor future interest expenses, leverage ratios, and the integration of Masimo. Despite recent stock weakness, analysts view Danaher as undervalued, noting its strong balance sheet despite increased debt.", "sentiment_score": 0.041322, "sentiment_label": "Neutral", "relevance_score": 0.595666, "sentiment": { "label": "negative", "score": -0.361, "confidence": 0.36 } }, { "source": "alpha_vantage", "title": "Thermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company", "url": "https://www.bizjournals.com/boston/news/2026/04/23/thermo-fisher-us-manufacturing.html", "date": "2026-04-23", "summary": "Thermo Fisher Scientific CEO Marc Casper stated that the Waltham-based company is already benefiting from domestic manufacturing efforts, anticipating further growth in the coming years. This \"tailwind\" is expected to be buoyed by onshoring initiatives, with former President Donald Trump having recently toured a Thermo Fisher facility to highlight his administration's focus on lowering drug prices and boosting domestic production.", "sentiment_score": 0.403074, "sentiment_label": "Bullish", "relevance_score": 0.986899, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market", "url": "https://www.marketwatch.com/data-news/thermo-fisher-scientific-inc-stock-falls-thursday-underperforms-market-acab3b67-659ce3ff98ea", "date": "2026-04-23", "summary": "Thermo Fisher Scientific Inc. (TMO) shares fell 9.20% on Thursday, closing at $466.70. This decline occurred during an overall poor trading day, as the S&P 500 Index (SPX) dropped 0.41% and the Dow Jones Industrial Average (DJIA) fell 0.36%. This marks the fourth consecutive day of losses for the stock.", "sentiment_score": -0.420702, "sentiment_label": "Bearish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Thermo Fisher falls after earnings top estimates, but growth concerns persist", "url": "https://www.proactiveinvestors.com/companies/news/1091089/thermo-fisher-falls-after-earnings-top-estimates-but-growth-concerns-persist-1091089.html", "date": "2026-04-23", "summary": "Thermo Fisher Scientific's shares fell over 7.5% despite beating first-quarter earnings estimates, as investors focused on modest underlying organic growth and a cautious outlook. While adjusted earnings per share and revenue both exceeded expectations, acquisitions drove a significant portion of the revenue increase, with organic growth at only 1%. The company raised its full-year revenue outlook but it remains slightly below consensus estimates, contributing to investor concerns about future g", "sentiment_score": -0.433173, "sentiment_label": "Bearish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.586, "confidence": 0.59 } }, { "source": "alpha_vantage", "title": "Thermo Fisher (TMO) Q1 2026 Earnings Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2026/04/23/thermo-fisher-tmo-q1-2026-earnings-transcript/", "date": "2026-04-23", "summary": "Thermo Fisher Scientific reported a strong start to 2026, with Q1 revenue up 6% to $11.01 billion and adjusted EPS increasing 6% to $5.44. The company raised its full-year 2026 guidance, boosted by the acquisition of Clario and robust operational performance. Key growth drivers included bioproduction and clinical research, while academic and government segments faced muted demand, particularly in the U.S. and China.", "sentiment_score": 0.495934, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Cumberland Pharmaceuticals to sell branded drug unit to Apotex for $100M", "url": "https://www.investing.com/news/company-news/cumberland-pharmaceuticals-to-sell-branded-drug-unit-to-apotex-for-100m-93CH-4632724", "date": "2026-04-23", "summary": "Cumberland Pharmaceuticals announced an agreement to sell its branded pharmaceutical line to an affiliate of Apotex for $100 million in cash, a deal representing more than twice Cumberland’s current market capitalization. The company will retain its product pipeline and its majority ownership in Cumberland Emerging Technologies Inc. Cumberland is actively developing ifetroban, a thromboxane antagonist, through three separate programs, including one for Duchenne muscular dystrophy with FDA design", "sentiment_score": 0.321452, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.641219, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "GE HealthCare to Post Q1 Earnings: What's in Store for the Stock?", "url": "https://www.tradingview.com/news/zacks:79dcafb13094b:0-ge-healthcare-to-post-q1-earnings-what-s-in-store-for-the-stock/", "date": "2026-04-23", "summary": "GE HealthCare Technologies Inc. (GEHC) is set to report its first-quarter 2026 earnings on April 29, with analysts anticipating sustained low-to-mid-single-digit organic revenue growth despite challenges in China and tariff-related costs. The company's prior quarter showed an earnings beat, and the upcoming report is expected to highlight strong performance in Pharmaceutical Diagnostics and stable growth in Imaging. However, a neutral Earnings ESP and a Zacks Rank #3 suggest the prediction for a", "sentiment_score": 0.288979, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.704275, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Reports First Quarter 2026 Results", "url": "https://www.pharmiweb.com/press-release/2026-04-23/thermo-fisher-scientific-reports-first-quarter-2026-results", "date": "2026-04-23", "summary": "Thermo Fisher Scientific reported strong first-quarter 2026 results, with revenue up 6% to $11.01 billion and diluted EPS growing 11% to $4.43. The company highlighted new product launches, strategic collaborations with NVIDIA and SHL Medical, and the acquisition of Clario, along with stock repurchases and a dividend increase. Thermo Fisher CEO Marc N. Casper emphasized excellent execution, the company's PPI Business System, and its commitment to driving innovation and customer success.", "sentiment_score": 0.53646, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Reports First Quarter 2026 Results", "url": "https://www.biospace.com/press-releases/thermo-fisher-scientific-reports-first-quarter-2026-results", "date": "2026-04-23", "summary": "Thermo Fisher Scientific announced strong first quarter 2026 results, with revenue growing 6% to $11.01 billion and adjusted diluted EPS increasing 6% to $5.44. The company highlighted its growth strategy through innovative product launches, strategic collaborations with NVIDIA and SHL Medical, and successful capital deployment including the acquisition of Clario and a 10% dividend increase. Management expressed confidence in delivering a strong year, emphasizing operational excellence and custo", "sentiment_score": 0.639753, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher ranks sixth by Quant as stock falls on Q1 results (TMO:NYSE)", "url": "https://seekingalpha.com/news/4578555-thermo-fisher-ranks-sixth-by-quant-as-stock-falls-on-q1-results", "date": "2026-04-23", "summary": "Thermo Fisher Scientific (TMO) shares declined in premarket trading despite exceeding Q1 2026 revenue expectations, as weaker-than-expected organic growth raised concerns about demand. The company's stock currently holds a \"Hold\" rating and ranks sixth among its life sciences tools peers by Seeking Alpha's Quant Ratings, which assess valuation, growth, momentum, and profitability.", "sentiment_score": -0.271952, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific slides 3% despite solid financial report 📉", "url": "https://www.xtb.com/int/market-analysis/news-and-research/thermo-fisher-scientific-slides-3-despite-solid-financial-report", "date": "2026-04-23", "summary": "Thermo Fisher Scientific reported strong first-quarter 2026 results, surpassing market expectations for adjusted EPS and revenue, yet its shares dipped 3% in premarket trading. The negative investor reaction is primarily attributed to weak organic revenue growth of only 1%, indicating that most expansion was driven by acquisitions rather than core business performance. Despite new product launches and strategic partnerships, the market prioritized the quality of underlying business growth over t", "sentiment_score": -0.283091, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.114, "confidence": 0.11 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific slides 3% despite solid financial report 📉", "url": "https://www.xtb.com/en/market-analysis/thermo-fisher-scientific-slides-3-despite-solid-financial-report", "date": "2026-04-23", "summary": "Thermo Fisher Scientific's shares declined by 3% in premarket trading despite reporting first-quarter 2026 results that surpassed market expectations for adjusted EPS and revenue. While the company saw 6% year-over-year growth in both metrics, organic revenue growth was a mere 1%, suggesting that acquisitions rather than core business strength drove expansion. The market reacted negatively, emphasizing the importance of underlying business growth quality over just beating estimates.", "sentiment_score": 0.055391, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.114, "confidence": 0.11 } }, { "source": "alpha_vantage", "title": "THERMO FISHER SCIENTIFIC ($TMO) Releases Q1 2026 Earnings", "url": "https://www.quiverquant.com/news/THERMO+FISHER+SCIENTIFIC+%28%24TMO%29+Releases+Q1+2026+Earnings", "date": "2026-04-23", "summary": "Thermo Fisher Scientific (TMO) announced its Q1 2026 earnings, reporting $5.44 per share, surpassing analyst estimates of $5.28. The company's revenue reached $11.005 billion, also exceeding estimates by over $45 million. The article also details recent insider trading activity, hedge fund movements, government contracts, congressional stock transactions, and analyst ratings and price targets for TMO.", "sentiment_score": 0.345028, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific reports Q1 2026: Revenue $11.01B, GAAP diluted EPS $4.43, Adjusted EPS $5.44", "url": "https://www.tradingview.com/news/tradingview:0e121427cd3e8:0-thermo-fisher-scientific-reports-q1-2026-revenue-11-01b-gaap-diluted-eps-4-43-adjusted-eps-5-44/", "date": "2026-04-23", "summary": "Thermo Fisher Scientific reported strong first-quarter 2026 results, with revenue reaching $11.01 billion and GAAP diluted EPS increasing 11% year-over-year to $4.43. The company also announced an adjusted diluted EPS of $5.44, up 6%, and highlighted active capital deployment including the acquisition of Clario, $3.0 billion in share repurchases, and a 10% dividend increase. Significant business developments included new product launches and strategic collaborations to advance scientific instrum", "sentiment_score": 0.470784, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher: Q1 Earnings Snapshot", "url": "https://www.kvue.com/article/syndication/associatedpress/thermo-fisher-q1-earnings-snapshot/616-23bd561b-ebd9-447b-a698-a4ea10e2f9e9", "date": "2026-04-23", "summary": "Thermo Fisher Scientific Inc. reported first-quarter net income of $1.65 billion, or $4.43 per share. Adjusted earnings were $5.44 per share, surpassing analyst expectations of $5.20 per share. The company's revenue of $11.01 billion also exceeded Street forecasts of $10.83 billion.", "sentiment_score": 0.533597, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Earnings Flash (TMO) Thermo Fisher Scientific Inc. Reports Q1 Revenue $11.01B, vs. FactSet Est of $10.86B", "url": "https://www.marketscreener.com/news/earnings-flash-tmo-thermo-fisher-scientific-inc-reports-q1-revenue-11-01b-vs-factset-est-of-1-ce7f59d9de89f622", "date": "2026-04-23", "summary": "Thermo Fisher Scientific Inc. (TMO) reported its Q1 revenue at $11.01 billion, exceeding the FactSet estimate of $10.86 billion. This news indicates a positive financial performance for the company in the first quarter, surpassing analyst expectations. The report suggests strong operational results for Thermo Fisher Scientific.", "sentiment_score": 0.441308, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Reports First Quarter 2026 Results", "url": "https://www.businesswire.com/news/home/20260422657369/en/Thermo-Fisher-Scientific-Reports-First-Quarter-2026-Results", "date": "2026-04-23", "summary": "Thermo Fisher Scientific (NYSE: TMO) reported a strong start to 2026 with first-quarter revenue increasing 6% to $11.01 billion and GAAP diluted EPS growing 11% to $4.43. The company highlighted strategic advancements including new product launches, collaborations with NVIDIA and SHL Medical, and the acquisition of Clario. Marc N. Casper, chairman and CEO, attributed the success to the company's growth strategy and PPI Business System, expressing optimism for the full year.", "sentiment_score": 0.433154, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "[8-K] THERMO FISHER SCIENTIFIC INC. Reports Material Event", "url": "https://www.stocktitan.net/sec-filings/TMO/8-k-thermo-fisher-scientific-inc-reports-material-event-cdcd9fc4e15e.html", "date": "2026-04-23", "summary": "Thermo Fisher Scientific Inc. reported Q1 2026 results including a 6% revenue increase to $11.01 billion and an 11% rise in GAAP diluted EPS to $4.43. The company also announced the acquisition of Clario, repurchased $3.0 billion in stock, and increased its dividend by 10%. Management will provide updated 2026 guidance during their earnings conference call.", "sentiment_score": 0.411647, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher tops $11B in quarterly sales, lifts dividend 10%", "url": "https://www.stocktitan.net/news/TMO/thermo-fisher-scientific-reports-first-quarter-2026-zubscfup7iu4.html", "date": "2026-04-23", "summary": "Thermo Fisher Scientific reported strong first-quarter 2026 results, with revenue growing 6% to $11.01 billion and adjusted diluted EPS increasing by 6% to $5.44. The company highlighted successful execution of its growth strategy, including new product launches, strategic collaborations with NVIDIA and SHL Medical, and the acquisition of Clario. Additionally, Thermo Fisher repurchased $3.0 billion of stock and raised its dividend by 10%, demonstrating confidence in its financial performance and", "sentiment_score": 0.445773, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.511, "confidence": 0.51 } }, { "source": "alpha_vantage", "title": "Thermo Fisher: Q1 Earnings Snapshot", "url": "https://www.ktvb.com/article/syndication/associatedpress/thermo-fisher-q1-earnings-snapshot/616-23bd561b-ebd9-447b-a698-a4ea10e2f9e9", "date": "2026-04-23", "summary": "Thermo Fisher Scientific Inc. reported first-quarter net income of $1.65 billion, or $4.43 per share. Adjusted earnings of $5.44 per share surpassed Wall Street expectations of $5.20 per share. The company also exceeded revenue forecasts, posting $11.01 billion against an expected $10.83 billion.", "sentiment_score": 0.440368, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Global Cloud ELN Service Market | USA, China, India Lead | Thermo Fisher Scientific, Agilent Technologies, Dassault Systèmes Drive Digital Lab Transformation", "url": "https://www.bolsamania.com/nota-de-prensa/mercados/global-cloud-eln-service-market-usa-china-india-lead-thermo-fisher-scientific-agilent-technologies-dassault-systemes-drive-digital-lab-transformation--22333068.html", "date": "2026-04-22", "summary": "The global Cloud Electronic Laboratory Notebook (ELN) Service market is poised for significant growth, projected to reach USD 1,156.0 million by 2035 from USD 375.1 million in 2025, driven by digital transformation in research, regulatory compliance needs, and demand for collaborative data management. Key growth regions include India, China, and the USA, with leading companies like Thermo Fisher Scientific, Agilent Technologies, and Dassault Systèmes spearheading this digital laboratory evolutio", "sentiment_score": 0.710334, "sentiment_label": "Bullish", "relevance_score": 0.870034, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Global Cloud ELN Service Market | USA, China, India Lead | Thermo Fisher Scientific, Agilent Technologies, Dassault Systèmes Drive Digital Lab Transformation", "url": "https://sg.finance.yahoo.com/news/global-cloud-eln-market-usa-155700233.html", "date": "2026-04-22", "summary": "The global Cloud ELN Service market is experiencing strong growth, projected to reach USD 1,156.0 million by 2035 from USD 375.1 million in 2025, driven by digital transformation, regulatory compliance, and increased demand for collaborative data management. Key players like Thermo Fisher Scientific, Agilent Technologies, and Dassault Systèmes are leading this sector, with software and cloud-based deployment being the dominant and fastest-growing segments. India, China, and the USA are identifie", "sentiment_score": 0.518911, "sentiment_label": "Bullish", "relevance_score": 0.933473, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "HiFi multiomics reveals how biology shapes life on Earth", "url": "https://www.pacb.com/blog/hifi-multiomics-reveals-how-biology-shapes-life-on-earth/", "date": "2026-04-22", "summary": "On Earth Day 2026, PacBio highlights how HiFi multiomic approaches are revolutionizing the understanding of biology across the planet. Recent studies using HiFi sequencing are revealing the intricate details of genomes, their function, adaptation, and interaction with environments. The article details multiomic investigations into somatic and germline mutations, chromosome-scale assemblies, epigenome mapping, transcriptome resolution, and microbial diversity, showcasing how these technologies ar", "sentiment_score": 0.272342, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.627352, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Global Cloud ELN Service Market | USA, China, India Lead | Thermo Fisher Scientific, Agilent Technologies, Dassault Systèmes Drive Digital Lab Transformation", "url": "https://finance.yahoo.com/sectors/technology/articles/global-cloud-eln-market-usa-155700233.html", "date": "2026-04-22", "summary": "The global Cloud Electronic Laboratory Notebook (ELN) Service market is expected to grow significantly, from USD 375.1 million in 2025 to USD 1,156.0 million by 2035, at a CAGR of 12.6%. This growth is driven by digital transformation in research, rising regulatory compliance needs, and demand for collaborative cloud-based data management, with key players like Thermo Fisher Scientific and Dassault Systèmes leading the charge. The market is propelled by a shift from paper-based systems to cloud-", "sentiment_score": 0.443806, "sentiment_label": "Bullish", "relevance_score": 0.877969, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Gene Expression Analysis Market Set for Robust Growth to USD 11.25 Billion by 2033, Driven by Precision Medicine and Genomics Advancements, with Thermo Fisher Scientific Inc., Illumina Inc., and QIAGEN N.V. Leading the Competitive Landscape", "url": "https://www.openpr.com/news/4483981/gene-expression-analysis-market-set-for-robust-growth-to-usd", "date": "2026-04-22", "summary": "The global Gene Expression Analysis Market is projected to reach USD 11.25 billion by 2033, growing at an 8.7% CAGR from USD 5.78 billion in 2025. This growth is driven by the increasing adoption of advanced genomic technologies in life sciences and healthcare, especially for precision medicine, biomarker discovery, and diagnostics. Key players like Thermo Fisher Scientific, Illumina, and QIAGEN are leading the market with advancements in sequencing, PCR, and bioinformatics.", "sentiment_score": 0.442082, "sentiment_label": "Bullish", "relevance_score": 0.994794, "sentiment": { "label": "positive", "score": 0.691, "confidence": 0.69 } }, { "source": "alpha_vantage", "title": "WST Likely to Beat Q1 Earnings Estimates: How to Play the Stock?", "url": "https://www.tradingview.com/news/zacks:d4a6d61b4094b:0-wst-likely-to-beat-q1-earnings-estimates-how-to-play-the-stock/", "date": "2026-04-21", "summary": "West Pharmaceutical Services (WST) is expected to surpass its first-quarter 2026 earnings estimates, with anticipated revenues between $770-$790 million and adjusted diluted EPS of $1.65-$1.70. The company's strong operational momentum, driven by its high-value product portfolio and GLP-1 demand, positions it for continued growth. With a positive Earnings ESP and a Zacks Rank #3, WST is predicted for an earnings beat.", "sentiment_score": 0.505562, "sentiment_label": "Bullish", "relevance_score": 0.64905, "sentiment": { "label": "positive", "score": 0.34, "confidence": 0.34 } }, { "source": "alpha_vantage", "title": "Metagenomics Market Key Companies Analysis - Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies, Qiagen, Bio-Rad Laboratories, Inc., Perkinelmer Inc., Illumina Inc. etc.", "url": "https://www.openpr.com/news/4482480/metagenomics-market-key-companies-analysis-merck-kgaa-thermo", "date": "2026-04-21", "summary": "The global metagenomics market continues its significant growth, driven by advancements in sequencing technologies, declining costs, and increasing applications across healthcare, biotechnology, agriculture, and environmental studies. Valued at US$ 165.8 million in 2018, it is projected to reach US$ 314.3 million by 2027, with a CAGR of 7.7%. Key players like Merck KGaA, Thermo Fisher Scientific, and Illumina Inc. are spearheading innovations, despite challenges such as high capital investment a", "sentiment_score": 0.033576, "sentiment_label": "Neutral", "relevance_score": 0.311484, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Revvity Inc. stock (US76155R1086): Why does its life sciences focus matter more for U.S. investors n", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/revvity-inc-stock-us76155r1086-why-does-its-life-sciences-focus-matter/69230275", "date": "2026-04-21", "summary": "Revvity Inc. (US76155R1086) is highlighted as a key player in life sciences discovery and diagnostics, offering stability and growth potential for U.S. investors due to its focus on essential technologies for drug development, genetic research, and clinical diagnostics. The company's business model, which provides high-precision instruments and recurring revenue streams from consumables and services, positions it well within the accelerating healthcare R&D sector. Analysts generally have a posit", "sentiment_score": -0.145613, "sentiment_label": "Neutral", "relevance_score": 0.647061, "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "alpha_vantage", "title": "Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing", "url": "https://www.stocktitan.net/news/AVTR/avantor-unifies-masterflex-portfolio-to-streamline-fluid-management-qe2ssxkrxb25.html", "date": "2026-04-21", "summary": "Avantor has unified its Masterflex fluid handling portfolio, now encompassing standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems. This expansion is designed to streamline fluid management from R&D to high-volume bioprocess manufacturing, including new PROFINET connectivity and storage containers. Avantor will showcase these integrated systems and provide a technical presentation at INTERPHEX 2026 in New York.", "sentiment_score": 0.117221, "sentiment_label": "Neutral", "relevance_score": 0.615374, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "New Zealand Herald", "title": "Blues v Reds result: Super Point victory sees Kiwi sides complete perfect weekend against Australians", "description": "NZ sides will finish the weekend unbeaten by Australian opponents.", "url": "https://www.nzherald.co.nz/sport/rugby/super-rugby/blues-v-reds-result-super-point-victory-sees-kiwi-sides-complete-perfect-weekend-against-australians/ZUIA5G56RZBV5FGSTABNYYFNME/", "date": "2026-04-25", "published_at": "2026-04-25T09:26:20Z", "sentiment": { "label": "positive", "score": 0.823, "confidence": 0.82 } }, { "source": "news", "source_name": "BBC News", "title": "Dragons beat Zebre for first away URC win in four years", "description": "David Richards scores a last-minute try as Dragons beat Zebre in Parma to end their United Rugby Championship away drought.", "url": "https://www.bbc.com/sport/rugby-union/articles/cj37dllvl75o", "date": "2026-04-24", "published_at": "2026-04-24T20:50:21Z", "sentiment": { "label": "positive", "score": 0.859, "confidence": 0.86 } }, { "source": "news", "source_name": "BBC News", "title": "Cardiff beat Ospreys to improve URC play-off hopes", "description": "Cardiff improve their United Rugby Championship play-off hopes with victory in the Welsh derby against Ospreys at the Arms Park.", "url": "https://www.bbc.com/sport/rugby-union/articles/c5yv1033lvgo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-24", "published_at": "2026-04-24T20:08:56Z", "sentiment": { "label": "positive", "score": 0.944, "confidence": 0.94 } }, { "source": "news", "source_name": "BBC News", "title": "Cardiff beat Ospreys to improve URC play-off hopes", "description": "Cardiff improve their United Rugby Championship play-off hopes with victory in the Welsh derby against Ospreys at the Arms Park.", "url": "https://www.bbc.com/sport/rugby-union/articles/c5yv1033lvgo", "date": "2026-04-24", "published_at": "2026-04-24T20:01:58Z", "sentiment": { "label": "positive", "score": 0.944, "confidence": 0.94 } }, { "source": "news", "source_name": "BBC News", "title": "Wales face arguably biggest task in sport - stopping England", "description": "Saturday's Six Nations action pits a team that has forgotten how to lose against a team that cannot remember how to win.", "url": "https://www.bbc.com/sport/rugby-union/articles/c5y9njl2040o", "date": "2026-04-24", "published_at": "2026-04-24T16:44:04Z", "sentiment": { "label": "negative", "score": -0.34, "confidence": 0.34 } }, { "source": "news", "source_name": "Plos.org", "title": "Development of a Loop-Mediated Isothermal Amplification (LAMP) for the screening of Candida auris", "description": "Background Candida auris is an emerging multidrug-resistant yeast associated with invasive infections, healthcare-associated outbreaks, and high mortality, and is often misidentified by conventional diagnostic methods. Rapid, accurate, and scalable screening …", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0348003", "date": "2026-04-24", "published_at": "2026-04-24T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "A functional crosstalk between circulating follicular helper 2 T cells and memory B cells drives anti-Plasmodium vivax antibodies", "description": "Author summary Naturally acquired immunity to malaria relies on humoral immunity which plays a crucial role in inhibiting parasite invasion. Interactions between Tfh and B cells in germinal centers contribute to MBC development and antibody production. Althou…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014232", "date": "2026-04-24", "published_at": "2026-04-24T14:00:00Z", "sentiment": { "label": "positive", "score": 0.557, "confidence": 0.56 } }, { "source": "news", "source_name": "Plos.org", "title": "Reappraisal of profibrotic phenotype and cell-cycle state of renal tubular epithelium after ischemia–reperfusion injury", "description": "Chronic kidney disease progression involves phenotypic changes in tubular epithelial cells, and recent studies have highlighted the relationship between such pro-fibrotic phenotypes and cell cycle arrest in injured tubular epithelial cells undergoing repair. …", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347835", "date": "2026-04-24", "published_at": "2026-04-24T14:00:00Z", "sentiment": { "label": "negative", "score": -0.784, "confidence": 0.78 } }, { "source": "news", "source_name": "Plos.org", "title": "MCL1 promotes porcine epidemic diarrhea virus replication by modulating arachidonic acid metabolic pathway", "description": "Author summary PEDV is a highly infectious enteropathogenic coronavirus that imposes an enormous economic burden on the global swine industry. Despite the ongoing identification of host factors involved in the viral life cycle, the mechanisms how these host f…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014170", "date": "2026-04-24", "published_at": "2026-04-24T14:00:00Z", "sentiment": { "label": "negative", "score": -0.291, "confidence": 0.29 } }, { "source": "news", "source_name": "Plos.org", "title": "Gut microbiome alterations among Ghanaian children with asymptomatic malaria infections", "description": "The human gut microbiome, consisting of bacteria, archaea, fungi, and viruses, influences various physiological processes of the body. The gut microbiome composition is shaped by factors such as diet, geography, and antibiotic use. Malaria has been a global h…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0348120", "date": "2026-04-24", "published_at": "2026-04-24T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "Targeted transferosomal delivery of cetirizine: A new approach to alopecia management", "description": "Introduction Androgenetic alopecia is common in males and females; its prevalence increases with age. It affects the social life of individuals worldwide. The main problem associated with conventional minoxidil treatment is the risk of facial hypertrichosis. …", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347648", "date": "2026-04-24", "published_at": "2026-04-24T14:00:00Z", "sentiment": { "label": "negative", "score": -0.586, "confidence": 0.59 } }, { "source": "news", "source_name": "Plos.org", "title": "Pregelatinized green banana flour snack bars: Physicochemical properties, sensory quality, and gastroprotective potential in an ethanol-induced ulcer model", "description": "Peptic ulcers remain a recurrent gastrointestinal disorder requiring preventive nutritional strategies. Functional foods that promote gastrointestinal health may play an important role in preventing and managing peptic ulcers. In this study, we evaluated preg…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347771", "date": "2026-04-24", "published_at": "2026-04-24T14:00:00Z", "sentiment": { "label": "positive", "score": 0.459, "confidence": 0.46 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Germany Concierge Medicine Market Report 2026-2034: Increasing Demand for Personalized and Preventive Healthcare and Willingness to Pay for Convenience and Time Efficiency Bolster Growth", "description": "The Germany concierge medicine market is poised for growth, expanding from $1 billion in 2025 to $2.2 billion by 2034, driven by a 9.12% CAGR. This rise is attributed to increasing demand for personalized healthcare, preference for shorter wait times, and pre…", "url": "https://www.globenewswire.com/news-release/2026/04/24/3280786/28124/en/Germany-Concierge-Medicine-Market-Report-2026-2034-Increasing-Demand-for-Personalized-and-Preventive-Healthcare-and-Willingness-to-Pay-for-Convenience-and-Time-Efficiency-Bolster-G.html", "date": "2026-04-24", "published_at": "2026-04-24T12:43:00Z", "sentiment": { "label": "positive", "score": 0.813, "confidence": 0.81 } }, { "source": "news", "source_name": "BBC News", "title": "Wing Woolley to make Scarlets debut against Bulls", "description": "Scarlets will give 20-year-old academy wing Callum Woolley his United Rugby Championship debut in Saturday's home game against Bulls.", "url": "https://www.bbc.com/sport/rugby-union/articles/c77m2l3emgzo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-24", "published_at": "2026-04-24T11:12:18Z", "sentiment": { "label": "positive", "score": 0.691, "confidence": 0.69 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Clinical Trial Data Visualization Research Report 2026: $1.82 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F", "description": "The clinical trial data visualization market is poised for growth, driven by the increasing complexity of trial data, expansion of decentralized trials, and rising demand for AI-driven visual analytics. Cloud-based and AI-powered solutions are enhancing real-…", "url": "https://www.globenewswire.com/news-release/2026/04/24/3280627/28124/en/Clinical-Trial-Data-Visualization-Research-Report-2026-1-82-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html", "date": "2026-04-24", "published_at": "2026-04-24T09:53:00Z", "sentiment": { "label": "positive", "score": 0.796, "confidence": 0.8 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Clinical Trial Management Systems Research Report 2026: $4+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F", "description": "Key opportunities in the clinical trial management systems market include the adoption of decentralized models, AI integration, and cloud-based platforms. Rapid growth is fueled by rising R&D investments, personalized medicine, and regulatory demands, with No…", "url": "https://www.globenewswire.com/news-release/2026/04/24/3280619/28124/en/Clinical-Trial-Management-Systems-Research-Report-2026-4-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html", "date": "2026-04-24", "published_at": "2026-04-24T09:27:00Z", "sentiment": { "label": "positive", "score": 0.818, "confidence": 0.82 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "AI-Powered Clinical Trial Site Feasibility Research Report 2026: $4.38 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F", "description": "The AI-powered clinical trial site feasibility market is poised for strong growth, fueled by rising complexity in trial designs, demand for data-driven planning, and expansion of global trials. Key opportunities include adopting AI-driven site selection model…", "url": "https://www.globenewswire.com/news-release/2026/04/24/3280609/28124/en/AI-Powered-Clinical-Trial-Site-Feasibility-Research-Report-2026-4-38-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html", "date": "2026-04-24", "published_at": "2026-04-24T09:05:00Z", "sentiment": { "label": "positive", "score": 1.0, "confidence": 1.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Decentralized Clinical Trials Research Report 2026: $19.55 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F", "description": "Key market opportunities in decentralized clinical trials include increased adoption of hybrid trial designs, AI-driven optimization, and virtual trial platforms driven by telemedicine and digital health expansions. This enhances patient recruitment efficienc…", "url": "https://www.globenewswire.com/news-release/2026/04/24/3280606/28124/en/Decentralized-Clinical-Trials-Research-Report-2026-19-55-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html", "date": "2026-04-24", "published_at": "2026-04-24T09:02:00Z", "sentiment": { "label": "positive", "score": 0.863, "confidence": 0.86 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Omics-Based Clinical Trials Research Report 2026: $47.78 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F", "description": "The omics-based clinical trials market thrives on opportunities like the increasing demand for personalized medicine, genomics advancements, AI-enabled recruitment, biomarker-driven designs, and regional growth in Asia-Pacific. Key trends include precision me…", "url": "https://www.globenewswire.com/news-release/2026/04/24/3280604/28124/en/Omics-Based-Clinical-Trials-Research-Report-2026-47-78-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html", "date": "2026-04-24", "published_at": "2026-04-24T08:59:00Z", "sentiment": { "label": "positive", "score": 0.859, "confidence": 0.86 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Clinical Trial Supplies Research Report 2026: $4.33 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F", "description": "Expanding clinical trials, decentralization, and digital trial tools offer key market opportunities. Increased demand for biologics, CRO outsourcing, temperature-controlled logistics, and regulatory focus are growth drivers. North America leads, while Asia-Pa…", "url": "https://www.globenewswire.com/news-release/2026/04/24/3280589/28124/en/Clinical-Trial-Supplies-Research-Report-2026-4-33-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html", "date": "2026-04-24", "published_at": "2026-04-24T08:40:00Z", "sentiment": { "label": "positive", "score": 0.844, "confidence": 0.84 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Clinical Trial Supply and Logistics Industry Report 2026: $7.92 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F", "description": "Opportunities in the clinical trial supply and logistics market include the rise in decentralized trials, demand for patient-centric models, expansion of biologics and cell therapy trials, and investment in digital logistics. Growth is expected in integrated …", "url": "https://www.globenewswire.com/news-release/2026/04/24/3280587/28124/en/Clinical-Trial-Supply-and-Logistics-Industry-Report-2026-7-92-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html", "date": "2026-04-24", "published_at": "2026-04-24T08:39:00Z", "sentiment": { "label": "positive", "score": 0.791, "confidence": 0.79 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Tissue Engineering Market to Grow at 12.95% CAGR Reaching USD 27.59 Billion by 2031, Driven by Advances in Regenerative Medicine and Biomaterials, Says Mordor Intelligence", "description": "The global tissue engineering market is driven by increasing demand for regenerative therapies, advancements in biomaterials and stem cell research, and rising applications in orthopedics and wound care, with North America leading and Asia-Pacific emerging as…", "url": "https://www.globenewswire.com/news-release/2026/04/24/3280568/0/en/Tissue-Engineering-Market-to-Grow-at-12-95-CAGR-Reaching-USD-27-59-Billion-by-2031-Driven-by-Advances-in-Regenerative-Medicine-and-Biomaterials-Says-Mordor-Intelligence.html", "date": "2026-04-24", "published_at": "2026-04-24T07:54:00Z", "sentiment": { "label": "positive", "score": 0.765, "confidence": 0.77 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Barium Carbonate Market Projected to Reach USD 1326.74 Million by 2035, Amid Increasing Demand from Construction, Ceramics, and Electronics Industries | Report by SNS Insider", "description": "The barium carbonate market is growing steadily due to increasing demand in construction materials, ceramics, specialty glass, and electronics, supported by rapid urbanization and expanding applications in electroceramics, coatings, and automotive sectors. Th…", "url": "https://www.globenewswire.com/news-release/2026/04/24/3280567/0/en/Barium-Carbonate-Market-Projected-to-Reach-USD-1326-74-Million-by-2035-Amid-Increasing-Demand-from-Construction-Ceramics-and-Electronics-Industries-Report-by-SNS-Insider.html", "date": "2026-04-24", "published_at": "2026-04-24T07:43:00Z", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "Nature.com", "title": "Habitual coffee intake shapes the microbiome, modifies physiology and cognition", "description": "Here, the authors investigate coffee’s impact on the microbiota–gut–brain axis and assess whether these effects occur independently of caffeine in healthy participants from two clinical trials.", "url": "https://www.nature.com/articles/s41467-026-71264-8", "date": "2026-04-24", "published_at": "2026-04-24T04:04:42Z", "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "news", "source_name": "Nature.com", "title": "PinkyCaMP: an mScarlet-based calcium sensor with enhanced brightness, photostability and multiplexing capabilities", "description": "PinkyCaMP is a red genetically encoded calcium indicator with improved brightness and photostability. Derived from mScarlet, it does not exhibit photoswitching upon blue light illumination and is therefore compatible with green sensors as well as blue-light-s…", "url": "https://www.nature.com/articles/s41592-026-03065-2", "date": "2026-04-24", "published_at": "2026-04-24T00:00:00Z", "sentiment": { "label": "positive", "score": 0.856, "confidence": 0.86 } }, { "source": "news", "source_name": "Nature.com", "title": "Direct RNA sequencing and signal alignment reveal RNA structure ensembles in a eukaryotic cell", "description": "sm-PORE-cupine combines SHAPE-based chemical probing with nanopore-based direct RNA sequencing to identify RNA structural ensembles in the SARS-CoV-2 genome and the Candida albicans transcriptome.", "url": "https://www.nature.com/articles/s41592-026-03069-y", "date": "2026-04-24", "published_at": "2026-04-24T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Electrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerability", "description": "D’Ambrosio et al. screen 10,480 electrophilic compounds for senolytic effects and show that senolytic chloroacetamides or GPX4 inhibitors selectively kill senescent cells by ferroptosis.", "url": "https://www.nature.com/articles/s41556-026-01921-z", "date": "2026-04-24", "published_at": "2026-04-24T00:00:00Z", "sentiment": { "label": "negative", "score": -0.823, "confidence": 0.82 } }, { "source": "news", "source_name": "Yahoo Entertainment", "title": "Thermo Fisher Scientific Inc. Q1 2026 Earnings Call Summary", "description": "", "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_54a5b53f-04c9-45ed-a3b1-051f0ece406c", "date": "2026-04-23", "published_at": "2026-04-23T16:49:32Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "RTE", "title": "Six Nations: France v Ireland - All you need to know", "description": "Ireland face France in round three of the Guinness Women's Six Nations on Saturday night. Find out all you need to know here.", "url": "https://www.rte.ie/sport/rugby/2026/0423/1569816-womens-six-nations-france-v-ireland-all-you-need-to-know-2026/", "date": "2026-04-23", "published_at": "2026-04-23T15:27:57Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Barchart.com", "title": "Stock Indexes Recover on Strength in Chipmakers", "description": "The S&P 500 Index ($SPX ) (SPY ) today is up +0.07%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) ...", "url": "https://www.barchart.com/story/news/1479447/stocks-turn-higher-on-strength-in-chipmakers", "date": "2026-04-23", "published_at": "2026-04-23T15:16:50Z", "sentiment": { "label": "positive", "score": 0.494, "confidence": 0.49 } }, { "source": "news", "source_name": "Plos.org", "title": "Sea urchin eggs contain a plastid-derived structure that contributes to their development", "description": "Development in the sea has long been thought to be a nutritional gamble that ends in starvation. This study shows that sea urchin eggs contain a plastid-derived structure and that the light-dependent activity of this plastid component influences phytohormone …", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003705", "date": "2026-04-23", "published_at": "2026-04-23T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "NGS Kits Market Forecasted to Skyrocket from USD 1.1 Billion to USD 11.5 Billion by 2035: Hospitals and Clinics Expected to Capture 45% Share", "description": "The NGS kits market presents significant opportunities driven by advancements in genomic sequencing, especially in DNA and RNA preparation kits. Innovation is fueled by reduced sequencing costs and increased demand for precise, efficient genomic solutions. Th…", "url": "https://www.globenewswire.com/news-release/2026/04/23/3280086/28124/en/NGS-Kits-Market-Forecasted-to-Skyrocket-from-USD-1-1-Billion-to-USD-11-5-Billion-by-2035-Hospitals-and-Clinics-Expected-to-Capture-45-Share.html", "date": "2026-04-23", "published_at": "2026-04-23T13:43:00Z", "sentiment": { "label": "positive", "score": 1.0, "confidence": 1.0 } }, { "source": "news", "source_name": "BBC News", "title": "No Y11 derby but rivalries resume in Cardiff", "description": "It might no longer be the \"Y11 derby\" but there is still plenty at stake when Cardiff host Ospreys in the URC Welsh derby on Friday night.", "url": "https://www.bbc.com/sport/rugby-union/articles/czx9je7x4w8o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-23", "published_at": "2026-04-23T11:12:28Z", "sentiment": { "label": "negative", "score": -0.527, "confidence": 0.53 } }, { "source": "news", "source_name": "BBC News", "title": "Dragons won't be distracted by semi-final - Tiatia", "description": "Dragons take a strong side to Zebre in the United Rugby Championship the weekend before their Challenge Cup semi-final.", "url": "https://www.bbc.com/sport/rugby-union/articles/cj37dllvl75o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-23", "published_at": "2026-04-23T11:06:40Z", "sentiment": { "label": "positive", "score": 0.884, "confidence": 0.88 } }, { "source": "news", "source_name": "Barchart.com", "title": "Stocks Slip Before the Open on U.S.-Iran Talks Uncertainty, Earnings and PMI Data in Focus", "description": "June S&P 500 E-Mini futures (ESM26) are down -0.53%, and June Nasdaq 100 E-Mini futures (NQM26) are down -0.56% this morning as stalled U.S.-Iran talks and...", "url": "https://www.barchart.com/story/news/1470681/stocks-slip-before-the-open-on-u-s-iran-talks-uncertainty-earnings-and-pmi-data-in-focus", "date": "2026-04-23", "published_at": "2026-04-23T10:33:31Z", "sentiment": { "label": "negative", "score": -0.494, "confidence": 0.49 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Central Nervous System (CNS) Biomarkers Global Market Analysis Report 2026: Focus on Alzheimer's, Multiple Sclerosis, ALS, Frontotemporal Dementia, Parkinson's Disease - Forecast to 2030", "description": "Key market opportunities in the CNS Biomarkers sector include utilizing AI and technologies like ML and NLP to enhance drug development, improve patient stratification, and optimize medication strategies. Focus areas include neurodegenerative diseases and per…", "url": "https://www.globenewswire.com/news-release/2026/04/23/3279653/28124/en/Central-Nervous-System-CNS-Biomarkers-Global-Market-Analysis-Report-2026-Focus-on-Alzheimer-s-Multiple-Sclerosis-ALS-Frontotemporal-Dementia-Parkinson-s-Disease-Forecast-to-2030.html", "date": "2026-04-23", "published_at": "2026-04-23T09:45:00Z", "sentiment": { "label": "positive", "score": 0.844, "confidence": 0.84 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "2025 Protein Synthesis Research Review and Global Market Forecasts to 2030", "description": "Opportunities lie in the expanding demand for protein therapeutics driven by chronic disease prevalence, advancements in cell-free systems, and personalized medicine. Growth is supported by companies enhancing efficiency through R&D in protein synthesis, desp…", "url": "https://www.globenewswire.com/news-release/2026/04/23/3279646/28124/en/2025-Protein-Synthesis-Research-Review-and-Global-Market-Forecasts-to-2030.html", "date": "2026-04-23", "published_at": "2026-04-23T09:16:00Z", "sentiment": { "label": "positive", "score": 0.818, "confidence": 0.82 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "2025 Diagnostics Market Research Review Report", "description": "Emerging markets and rising healthcare expenditures drive demand for advanced diagnostic tools. Opportunities include personalized medicine, AI investments, and non-oncology applications, with a focus on value-based healthcare and low-cost home care technolog…", "url": "https://www.globenewswire.com/news-release/2026/04/23/3279640/28124/en/2025-Diagnostics-Market-Research-Review-Report.html", "date": "2026-04-23", "published_at": "2026-04-23T09:07:00Z", "sentiment": { "label": "positive", "score": 0.743, "confidence": 0.74 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Cancer Biomarkers Market Research Report 2026: Asia Pacific is a High-potential Region Fueled by Increased Healthcare Spending, While Genetic and Epigenetic Segments Drive Innovation", "description": "Emerging opportunities in the cancer biomarkers market include the growth of personalized oncology, non-invasive diagnostics, and omics technologies. The Asia Pacific is a high-potential region fueled by increased healthcare spending, while genetic and epigen…", "url": "https://www.globenewswire.com/news-release/2026/04/23/3279611/28124/en/Cancer-Biomarkers-Market-Research-Report-2026-Asia-Pacific-is-a-High-potential-Region-Fueled-by-Increased-Healthcare-Spending-While-Genetic-and-Epigenetic-Segments-Drive-Innovation.html", "date": "2026-04-23", "published_at": "2026-04-23T08:02:00Z", "sentiment": { "label": "positive", "score": 0.252, "confidence": 0.25 } }, { "source": "news", "source_name": "Nature.com", "title": "TBL1X/TBL1XR1 govern β-cell identity through a PAX6-containing gene regulatory network", "description": "Here they identify TBL/R1 as regulator of insulin levels and pancreatic β-cell identity. Mice with β-cell TBL/R1 deficiency display diabetes and interactome screens reveal a regulatory network including PAX6, verified in human β-cells.", "url": "https://www.nature.com/articles/s41467-026-72077-5", "date": "2026-04-23", "published_at": "2026-04-23T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Barchart.com", "title": "Stocks Settle Higher as Nasdaq Posts a Record High on Tech Strength", "description": "The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up +1.05%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.69%, and the Nasdaq 100 Index (...", "url": "https://www.barchart.com/story/news/1459130/stocks-settle-higher-as-nasdaq-posts-a-record-high-on-tech-strength", "date": "2026-04-22", "published_at": "2026-04-22T20:35:34Z", "sentiment": { "label": "positive", "score": 0.494, "confidence": 0.49 } }, { "source": "news", "source_name": "Yahoo Entertainment", "title": "Thermo Fisher (TMO) Q4 2024 Earnings Transcript", "description": "", "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_08483f41-cb08-42e2-860b-aa00c634ddb6", "date": "2026-04-22", "published_at": "2026-04-22T19:58:20Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "BleepingComputer", "title": "Spain dismantles major $4.7M manga piracy platform, arrests four", "description": "The Spanish police have dismantled the largest Spanish-language manga piracy platform, operating since 2014, with millions of monthly users from around the globe. [...]", "url": "https://www.bleepingcomputer.com/news/security/spain-dismantles-major-47m-manga-piracy-platform-arrests-four/", "date": "2026-04-22", "published_at": "2026-04-22T15:06:34Z", "sentiment": { "label": "negative", "score": -0.44, "confidence": 0.44 } }, { "source": "news", "source_name": "Plos.org", "title": "In vivo mouse model of calcific myonecrosis induced by injury", "description": "Skeletal muscle is the major tissue that provides a space and source for bone, which is formed by osteoblasts through the secretion of extracellular matrices, such as type I collagen, and the deposition of hydroxyapatite calcium phosphate crystals. In the pre…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346816", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "negative", "score": -0.421, "confidence": 0.42 } }, { "source": "news", "source_name": "Plos.org", "title": "Antitumoral immunity induced by gel ethanol ablation to treat unresectable colorectal cancer metastases in the liver", "description": "Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide. A quarter of CRC patients develop liver metastases. Treatment options for liver metastases include surgically removing the tumors or undergoing liver transplantation; howe…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347625", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "negative", "score": -0.796, "confidence": 0.8 } }, { "source": "news", "source_name": "Plos.org", "title": "Structure of the human P2X3 receptor reveals the basis for subtype-selective inhibition by sivopixant", "description": "P2X receptors are membrane ion channels that are targets for treating chronic pain and cough, motivating efforts to develop subtype-selective negative allosteric modulators (NAMs). This study solves the cryo-EM structure of the human P2X3 receptor in complex …", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003777", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "negative", "score": -0.637, "confidence": 0.64 } }, { "source": "news", "source_name": "Plos.org", "title": "Nicotinamide metabolism is essential for Hepatitis C Virus replication and the production of infectious Lipo-Viro-Particles", "description": "Author summary Hepatitis C virus (HCV) produces highly infectious particles known as lipo-viro-particles (LVPs), which are characterized by an unusually high lipid content. The formation of these particles relies on the host cell’s lipid metabolism, but the m…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014165", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "Beyond Clavulanic Acid biosynthesis: Exploring the broad regulatory impact of BldD in Streptomyces clavuligerus ATCC 27064", "description": "BldD is a global regulator of morphological development in Streptomyces, usually acting as a repressor of aerial mycelium formation. However, its role in metabolism and secondary biosynthesis in the wild-type strain Streptomyces clavuligerus remains poorly un…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347564", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "negative", "score": -0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Coagulation Analyzer Market Size to Reach a Valuation of USD 7.87 Billion by 2035; Increasing Incidence of Blood Disorders to Propel Market Expansion Globally | SNS Insider", "description": "Coagulation analyzer market grows with rising CVD, surgeries, and automation demand, driven by diagnostics accuracy, and lab expansion....", "url": "https://www.globenewswire.com/news-release/2026/04/22/3279119/0/en/Coagulation-Analyzer-Market-Size-to-Reach-a-Valuation-of-USD-7-87-Billion-by-2035-Increasing-Incidence-of-Blood-Disorders-to-Propel-Market-Expansion-Globally-SNS-Insider.html", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "negative", "score": -0.103, "confidence": 0.1 } }, { "source": "news", "source_name": "Plos.org", "title": "Modeling neonatal immune response to B. pertussis identifies early B cell activation and differentiation", "description": "Author summary Pertussis disease is mainly caused by the infection of the respiratory tract by the Gram-negative bacterium Bordetella pertussis. Despite global vaccination efforts, pertussis outbreaks continue to threaten neonates and young infants who face t…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014163", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "negative", "score": -0.103, "confidence": 0.1 } }, { "source": "news", "source_name": "Plos.org", "title": "Serological evidence of Borrelia turicatae in Raccoons (Procyon lotor) from an endemic focus of tick-borne relapsing fever in Mexico", "description": "Author summary Despite being originally described in Mexico, tick-borne relapsing fever caused by Borrelia turicatae is poorly understood and understudied. Historical and recent findings show that Ornithodoros turicata is distributed from central to northwest…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014242", "date": "2026-04-22", "published_at": "2026-04-22T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Zinc Citrate Market Size to Reach USD 3.73 Billion by 2035, Fueled by Rising Demand in Supplements and Oral Care Applications | Research by SNS Insider", "description": "The zinc citrate market is growing steadily due to its high bioavailability and low gastrointestinal irritation, driving increasing use across dietary supplements, pharmaceuticals, food fortification, and oral care products. The zinc citrate market is growing…", "url": "https://www.globenewswire.com/news-release/2026/04/22/3278774/0/en/Zinc-Citrate-Market-Size-to-Reach-USD-3-73-Billion-by-2035-Fueled-by-Rising-Demand-in-Supplements-and-Oral-Care-Applications-Research-by-SNS-Insider.html", "date": "2026-04-22", "published_at": "2026-04-22T10:30:00Z", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "$10+ Bn Microbiology Testing Market Analysis by Product, Technology, End User - Global Forecast to 2031", "description": "The global microbiology testing market is set to reach USD 10.09 billion by 2031, growing from USD 7.79 billion in 2026 at a CAGR of 5.3%. Growth is driven by rising contamination risks in food, water, and environmental sectors, along with advances in testing…", "url": "https://www.globenewswire.com/news-release/2026/04/22/3278699/28124/en/10-Bn-Microbiology-Testing-Market-Analysis-by-Product-Technology-End-User-Global-Forecast-to-2031.html", "date": "2026-04-22", "published_at": "2026-04-22T08:24:00Z", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Syngenta Deploys Tetra OS to Accelerate Scientific Discovery Through Industrial-Scale Data Automation", "description": "BOSTON, April 22, 2026 (GLOBE NEWSWIRE) --  TetraScience, the Scientific Data and AI Company, today announced that Syngenta has selected Tetra OS to power digital automation and data transformation in its Crop Protection R&D organization. This move is set to …", "url": "https://www.globenewswire.com/news-release/2026/04/22/3278663/0/en/Syngenta-Deploys-Tetra-OS-to-Accelerate-Scientific-Discovery-Through-Industrial-Scale-Data-Automation.html", "date": "2026-04-22", "published_at": "2026-04-22T06:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Astrocytes connect specific brain regions through plastic networks", "description": "Communication between distant brain regions is mediated by plastic networks of gap junction-coupled astrocytes.", "url": "https://www.nature.com/articles/s41586-026-10426-6", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Mechanically driven Li dendrite penetration in garnet solid electrolyte", "description": "Cryogenic electron microscopy images and micromechanical fracture modelling of mechanically soft lithium dendrites fracturing hard ceramic electrolytes suggest the mechanisms driving the phenomenon as well as design implications for solid-state lithium metal …", "url": "https://www.nature.com/articles/s41586-026-10415-9", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "news", "source_name": "Nature.com", "title": "Focal white matter lesions drive grey matter inflammation and synapse loss", "description": "A transient grey matter microgliosis is required for remyelination, the failure of which results in a chronic neuroinflammatory state seen in neurodegenerative disorders.", "url": "https://www.nature.com/articles/s41586-026-10414-w", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "negative", "score": -0.799, "confidence": 0.8 } }, { "source": "news", "source_name": "Nature.com", "title": "Myosin forces remodel F-actin for mechanosensitive protein recognition", "description": "Structural studies demonstrate that myosin generates forces that cause structural changes in actin, modulating cooperative binding by α-catenin and thus signal transduction and intercellular communication via adhesion complexes.", "url": "https://www.nature.com/articles/s41586-026-10398-7", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Dynamics of genetic and somatic trade-offs in ageing and mortality", "description": "Mapping DNA variants that modulate mortality using a starting population of 6,438 young mice defined 29 distinct loci that influence lifespan and mortality with divergent age- and sex-specific effects, as well as 30 loci that&nbs…", "url": "https://www.nature.com/articles/s41586-026-10407-9", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "positive", "score": 0.294, "confidence": 0.29 } }, { "source": "news", "source_name": "Nature.com", "title": "H2O2 repurposes plant O2 sensing to regulate post-hypoxia responses", "description": "Experiments in Arabidopsis demonstrate that group VII ethylene response factors show differential responses to different stimuli, enabling plants in flood-prone environments to adapt to both submergence-induced hypoxia and reoxygenation upon desubmergence.", "url": "https://www.nature.com/articles/s41586-026-10366-1", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer", "description": "The Lap-NET1 phase 1b trial reports that combined netrin1 antibody (NP137) plus modified FOLFIRINOX therapy on patients with locally advanced pancreatic cancer was well tolerated and improved progression-free survival and overall survival via inhibition of ep…", "url": "https://www.nature.com/articles/s41586-026-10436-4", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "negative", "score": -0.727, "confidence": 0.73 } }, { "source": "news", "source_name": "Nature.com", "title": "Electronic origin of reorganization energy in interfacial electron transfer", "description": "By tuning graphene’s electronic density of states, the study shows electrode electronic structure—not just the electrolyte—dominates reorganization energy and thus controls outer-sphere electron-transfer rates at solid–liquid interfaces.", "url": "https://www.nature.com/articles/s41586-026-10311-2", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "positive", "score": 0.494, "confidence": 0.49 } }, { "source": "news", "source_name": "Nature.com", "title": "Early fibrotic niches establish tumour-permissive microenvironments", "description": "Pathologic transformation in KrasG12D-mutant alveolar type II cells initiates a tumour-permissive niche by orchestrating epithelial, stromal and immune reprogramming through amphiregulin–EGFR signalling, creating a self-sustaining circuit critical for lung tu…", "url": "https://www.nature.com/articles/s41586-026-10399-6", "date": "2026-04-22", "published_at": "2026-04-22T00:00:00Z", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "Plos.org", "title": "Genomic and functional adaptations in the guanylate-binding protein 5 highlight specificities of bat antiviral innate immunity", "description": "Bats harbor many zoonotic viruses yet remain asymptomatic, and the evolutionary basis of their antiviral tolerance remains unclear. This study shows that bat GBP5 evolved under positive selection, driving virus-specific restriction and lineage-specific loss o…", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003760", "date": "2026-04-21", "published_at": "2026-04-21T14:00:00Z", "sentiment": { "label": "positive", "score": 0.221, "confidence": 0.22 } }, { "source": "news", "source_name": "Plos.org", "title": "Inducible gene deletion reveals essentiality of protein kinases and a septation initiation network in Candida albicans", "description": "Author summary Elucidating the function of essential genes in the biology of an organism is challenging, because mutants lacking an essential gene are inviable and cannot be recovered by standard methods. To investigate the importance of a set of putative ess…", "url": "https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1012118", "date": "2026-04-21", "published_at": "2026-04-21T14:00:00Z", "sentiment": { "label": "positive", "score": 0.477, "confidence": 0.48 } }, { "source": "news", "source_name": "Plos.org", "title": "Sugar, mineral, B-vitamins profiles and radical scavenging activity of Royal jelly collected at different harvesting times", "description": "Royal jelly is produced by young worker honeybees that support the growth of their larvae. Human beings can harvest and use it as functional food due to its high content of nutrients and beneficial human health effects. This study aims to investigate how harv…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347342", "date": "2026-04-21", "published_at": "2026-04-21T14:00:00Z", "sentiment": { "label": "positive", "score": 0.802, "confidence": 0.8 } }, { "source": "news", "source_name": "Plos.org", "title": "Efficacy of oxfendazole treatment against infective larvae of Litomosoides sigmodontis", "description": "Author summary Filarial worms can cause debilitating diseases and affect millions of people worldwide. New drugs are urgently needed to facilitate the elimination of filarial infections and improve the well-being and health of affected patients. Oxfendazole i…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014268", "date": "2026-04-21", "published_at": "2026-04-21T14:00:00Z", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Zika Virus Testing Market Set to Surpass USD 480 Million by 2035 – SNS Insider", "description": "Rising Demand for Prenatal Screening and advanced molecular diagnostics Fuel a Steady 7.28% CAGR Growth Rising Demand for Prenatal Screening and advanced molecular diagnostics Fuel a Steady 7.28% CAGR Growth", "url": "https://www.globenewswire.com/news-release/2026/04/21/3277812/0/en/Zika-Virus-Testing-Market-Set-to-Surpass-USD-480-Million-by-2035-SNS-Insider.html", "date": "2026-04-21", "published_at": "2026-04-21T11:37:00Z", "sentiment": { "label": "positive", "score": 0.735, "confidence": 0.74 } }, { "source": "news", "source_name": "Yahoo Entertainment", "title": "TD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating", "description": "", "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_ac265b57-a631-42c7-b6da-34a37304ec67", "date": "2026-04-21", "published_at": "2026-04-21T10:53:22Z", "sentiment": { "label": "negative", "score": -0.128, "confidence": 0.13 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Biotechnology Instruments Market Analysis Report 2026-2035: Unified Frameworks Combining Genomics and Proteomics Underpin New Strategic Market Developments", "description": "The biotechnology instruments market is growing due to personalized medicine, genomics, and molecular diagnostics. Opportunities lie in integrated multi-omics platforms and automation. Challenges include high costs. North America leads the market, with key pl…", "url": "https://www.globenewswire.com/news-release/2026/04/21/3277728/28124/en/Biotechnology-Instruments-Market-Analysis-Report-2026-2035-Unified-Frameworks-Combining-Genomics-and-Proteomics-Underpin-New-Strategic-Market-Developments.html", "date": "2026-04-21", "published_at": "2026-04-21T10:12:00Z", "sentiment": { "label": "positive", "score": 0.735, "confidence": 0.74 } }, { "source": "news", "source_name": "Nature.com", "title": "Laser-induced nucleation of magnetic hopfions", "description": "The creation of stable and isolated magnetic hopfions—three-dimensional topological solitons—has remained experimentally challenging. Now the laser-induced nucleation of hopfions has been achieved in a chiral magnet.", "url": "https://www.nature.com/articles/s41567-026-03236-0", "date": "2026-04-21", "published_at": "2026-04-21T00:00:00Z", "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global Continuous Emission Monitoring Systems Market Size/Share Worth USD 9.67 Billion by 2035 at a 9.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)", "description": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Continuous Emission Monitoring Systems Market size & share revenue was valued at approximately USD 4.02 Billion in 2025 and is e…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3277389/0/en/Global-Continuous-Emission-Monitoring-Systems-Market-Size-Share-Worth-USD-9-67-Billion-by-2035-at-a-9-2-CAGR-Custom-Market-Insights-Analysis-Outlook-Leaders-Report-Trends-Forecast-.html", "date": "2026-04-20", "published_at": "2026-04-20T19:30:00Z", "sentiment": { "label": "positive", "score": 0.796, "confidence": 0.8 } }, { "source": "news", "source_name": "The Irish Times", "title": "Owen Doyle: When did it become okay for referees to address players like old chums?", "description": "Andrew Brace was the latest official to adopt this soft approach. Trust me, it’s a waste of breath", "url": "https://www.irishtimes.com/sport/rugby/2026/04/20/owen-doyle-when-did-it-become-okay-for-rugby-referees-to-address-players-like-old-chums/", "date": "2026-04-20", "published_at": "2026-04-20T17:25:57Z", "sentiment": { "label": "positive", "score": 0.681, "confidence": 0.68 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Arrayed CRISPR Screening Market Presents Lucrative Opportunities Through 2026-2030: Total Revenue to Grow by $1.64 Billion at 17.7% CAGR", "description": "Industry poised for growth, driven by advancements in precision drug discovery, rising gene therapy investments, and personalized medicine adoption Industry poised for growth, driven by advancements in precision drug discovery, rising gene therapy investments…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3277327/28124/en/Arrayed-CRISPR-Screening-Market-Presents-Lucrative-Opportunities-Through-2026-2030-Total-Revenue-to-Grow-by-1-64-Billion-at-17-7-CAGR.html", "date": "2026-04-20", "published_at": "2026-04-20T16:35:00Z", "sentiment": { "label": "positive", "score": 0.869, "confidence": 0.87 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Cell Free Expression Industry Set to Reach USD 627 Million by 2035 - Investment in Cell Free Systems Surpasses USD 8 Billion in Last Six Years", "description": "The cell free expression market presents significant opportunities in developing diverse biomolecules, driven by demand from pharmaceutical and biotech sectors The cell free expression market presents significant opportunities in developing diverse biomolecul…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3277317/28124/en/Cell-Free-Expression-Industry-Set-to-Reach-USD-627-Million-by-2035-Investment-in-Cell-Free-Systems-Surpasses-USD-8-Billion-in-Last-Six-Years.html", "date": "2026-04-20", "published_at": "2026-04-20T16:26:00Z", "sentiment": { "label": "positive", "score": 0.962, "confidence": 0.96 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Single Use Bioprocessing Markets and Competition Insights Report 2026 - Industry Set to Triple in Value by 2035, Reaching USD 15.5 Billion", "description": "The single-use bioprocessing market offers significant growth opportunities, driven by the demand for enhanced productivity, flexibility, and cost-efficiency. Asia-Pacific is emerging as a key growth region. The single-use bioprocessing market offers signific…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3277301/28124/en/Single-Use-Bioprocessing-Markets-and-Competition-Insights-Report-2026-Industry-Set-to-Triple-in-Value-by-2035-Reaching-USD-15-5-Billion.html", "date": "2026-04-20", "published_at": "2026-04-20T16:07:00Z", "sentiment": { "label": "positive", "score": 0.914, "confidence": 0.91 } }, { "source": "news", "source_name": "Plos.org", "title": "Prion propagation is controlled by a hierarchical network involving the nuclear Tfap2c and hnRNP K factors and the cytosolic mTORC1 complex", "description": "Author summary Prion diseases are fatal brain disorders caused by misfolded forms of the cellular prion protein known as prions. Unlike most infectious agents, prions propagate by converting the normal prion protein into the misfolded form, triggering a self-…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014056", "date": "2026-04-20", "published_at": "2026-04-20T14:00:00Z", "sentiment": { "label": "negative", "score": -0.542, "confidence": 0.54 } }, { "source": "news", "source_name": "Plos.org", "title": "Systemic iron availability differentially shapes tumor and brain iron handling in a sex-dependent manner in glioblastoma", "description": "Iron is essential for normal physiological function, yet dysregulation of iron metabolism is increasingly recognized as a hallmark of cancers such as glioblastoma (GBM). Recent clinical evidence suggests that systemic iron deficiency anemia (IDA) negatively i…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0347520", "date": "2026-04-20", "published_at": "2026-04-20T14:00:00Z", "sentiment": { "label": "negative", "score": -0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "Plos.org", "title": "Entry, replication and innate immunity evasion of BANAL-236, a SARS-CoV-2-related bat virus, in Rhinolophus and human cells", "description": "Author summary Bats are known reservoirs for viruses that cause severe diseases in humans, such as coronaviruses and filoviruses. Bat species naturally or experimentally infected with these viruses rarely exhibit clinical symptoms, suggesting an evolved toler…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013573", "date": "2026-04-20", "published_at": "2026-04-20T14:00:00Z", "sentiment": { "label": "negative", "score": -0.7, "confidence": 0.7 } }, { "source": "news", "source_name": "Plos.org", "title": "Cadherin-11 serves as a novel receptor for Fusobacterium nucleatum adhesin FadA to exacerbate pulmonary inflammation", "description": "Author summary In this study, we investigated how Fusobacterium nucleatum, a bacterium commonly associated with periodontal disease, contributes to the worsening of pulmonary diseases such as chronic obstructive pulmonary disease (COPD). We discovered that a …", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014158", "date": "2026-04-20", "published_at": "2026-04-20T14:00:00Z", "sentiment": { "label": "negative", "score": -0.178, "confidence": 0.18 } }, { "source": "news", "source_name": "Plos.org", "title": "Dominance modifiers at the Arabidopsis self-incompatibility locus retain proto-miRNA features and act through non-canonical pathways", "description": "Author summary Many plants avoid self-fertilization through a system of self-incompatibility, which allows them to recognize and reject their own pollen. In plants like those in the Arabidopsis family, self-incompatibility operates through a “lock-and-key” sy…", "url": "https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1012127", "date": "2026-04-20", "published_at": "2026-04-20T14:00:00Z", "sentiment": { "label": "negative", "score": -0.153, "confidence": 0.15 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Softgel Capsules Market Analysis Report 2025 - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030", "description": "The Global Softgel Capsules Market offers key opportunities due to rising dietary supplement demand, health awareness, and plant-based trend adoption. Increased consumer preference for preventive health and vegan products supports market growth despite high p…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3277131/28124/en/Softgel-Capsules-Market-Analysis-Report-2025-Global-Industry-Size-Share-Trends-Opportunity-Forecast-2020-2030.html", "date": "2026-04-20", "published_at": "2026-04-20T13:27:00Z", "sentiment": { "label": "positive", "score": 0.906, "confidence": 0.91 } }, { "source": "news", "source_name": "Techtarget.com", "title": "OpenAI debuts AI model GPT-Rosalind to speed up drug discovery", "description": "Biopharma companies, including Moderna and Amgen, are working with OpenAI to integrate its new artificial intelligence model into their workflows to accelerate research and discovery.", "url": "https://www.techtarget.com/pharmalifesciences/news/366641922/OpenAI-debuts-AI-model-GPT-Rosalind-to-speed-up-drug-discovery", "date": "2026-04-20", "published_at": "2026-04-20T13:15:00Z", "sentiment": { "label": "positive", "score": 0.477, "confidence": 0.48 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Chemical Sensors Market Size to Grow USD 58.24 Billion by 2035 | Research by SNS Insider", "description": "Global Chemical Sensors Market Size, Share, Revenue Trends & Segmentation, By Type, Application, Technology, End Use and Region | Forecast 2035...", "url": "https://www.globenewswire.com/news-release/2026/04/20/3276886/0/en/Chemical-Sensors-Market-Size-to-Grow-USD-58-24-Billion-by-2035-Research-by-SNS-Insider.html", "date": "2026-04-20", "published_at": "2026-04-20T11:30:00Z", "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Healthcare Filtration Markets 2025-2035 with Focus on Biologics Manufacturing Featuring Alfa Laval, Asahi Kasei, Cobetter, Corning, Merck, Pall, Parker Hannifin, Sartorius, Thermo Fisher Scientific", "description": "Rapid growth in biologics is fueling the biopharmaceutical filtration market. Key opportunities include membrane filtration systems and single-use technologies, with North America and Europe leading. Innovations and mergers in filtration technologies are vita…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3276830/28124/en/Healthcare-Filtration-Markets-2025-2035-with-Focus-on-Biologics-Manufacturing-Featuring-Alfa-Laval-Asahi-Kasei-Cobetter-Corning-Merck-Pall-Parker-Hannifin-Sartorius-Thermo-Fisher-S.html", "date": "2026-04-20", "published_at": "2026-04-20T10:44:00Z", "sentiment": { "label": "positive", "score": 0.837, "confidence": 0.84 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Dengue Testing Market Size to be Valued at USD 971.11 Million by 2035; Industry Growth is Driven by the Increase in Dengue Cases in Tropical and Sub-tropical Nations Globally | SNS Insider", "description": "Dengue testing market grows with rising cases, rapid diagnostics, RT-PCR adoption, and strong public health initiatives driving global demand....", "url": "https://www.globenewswire.com/news-release/2026/04/20/3276781/0/en/Dengue-Testing-Market-Size-to-be-Valued-at-USD-971-11-Million-by-2035-Industry-Growth-is-Driven-by-the-Increase-in-Dengue-Cases-in-Tropical-and-Sub-tropical-Nations-Globally-SNS-In.html", "date": "2026-04-20", "published_at": "2026-04-20T09:30:00Z", "sentiment": { "label": "positive", "score": 0.863, "confidence": 0.86 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Cell Line Characterization and Cell Line Development Market Trends and Global Forecasts 2025-2035: 200+ Biologics Entered the Market with More Than 10,000 Candidates Undergoing Clinical Assessment", "description": "Opportunities include the rising demand for innovative biologics and the increased need for diverse cell lines, including mammalian, microbial, and insect. Growing trends in outsourcing and the expanding Asia-Pacific market also present significant growth pro…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3276740/28124/en/Cell-Line-Characterization-and-Cell-Line-Development-Market-Trends-and-Global-Forecasts-2025-2035-200-Biologics-Entered-the-Market-with-More-Than-10-000-Candidates-Undergoing-Clini.html", "date": "2026-04-20", "published_at": "2026-04-20T08:02:00Z", "sentiment": { "label": "positive", "score": 0.881, "confidence": 0.88 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Urology Devices Market to Reach $58.63 Billion by 2031 with Robotic Urologic Surgery Systems Projected to Expand at a 10.31% CAGR, Reports Mordor Intelligence", "description": "The urology devices market is driven by increasing prevalence of kidney stones, urinary incontinence, and prostate disorders, alongside growing adoption of minimally invasive procedures, with North America leading and Asia-Pacific emerging as a high-growth re…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3276724/0/en/Urology-Devices-Market-to-Reach-58-63-Billion-by-2031-with-Robotic-Urologic-Surgery-Systems-Projected-to-Expand-at-a-10-31-CAGR-Reports-Mordor-Intelligence.html", "date": "2026-04-20", "published_at": "2026-04-20T07:17:00Z", "sentiment": { "label": "positive", "score": 0.735, "confidence": 0.74 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Viral Vectors & Plasmid DNA Manufacturing Market Size Worth USD 29.82 Bn by 2035 Growing Demand for Gene and Cell Therapies Drives the Market", "description": "The globe viral vectors & plasmid DNA manufacturing market size is expected to be lead USD 29.82 billion by 2035, increasing from USD 7.26 billion in 2025, with a strong CAGR of 15.17% from 2026 to 2035. The globe viral vectors & plasmid DNA manufacturing mar…", "url": "https://www.globenewswire.com/news-release/2026/04/20/3276715/0/en/Viral-Vectors-Plasmid-DNA-Manufacturing-Market-Size-Worth-USD-29-82-Bn-by-2035-Growing-Demand-for-Gene-and-Cell-Therapies-Drives-the-Market.html", "date": "2026-04-20", "published_at": "2026-04-20T06:26:00Z", "sentiment": { "label": "positive", "score": 0.66, "confidence": 0.66 } }, { "source": "news", "source_name": "BBC News", "title": "Ospreys hold on to deny Sharks in Bridgend", "description": "Ospreys keep slim United Rugby Championship play-off hopes alive with a tense win against Sharks in Bridgend.", "url": "https://www.bbc.com/sport/rugby-union/articles/czxr20en016o", "date": "2026-04-18", "published_at": "2026-04-18T20:49:45Z", "sentiment": { "label": "positive", "score": 0.878, "confidence": 0.88 } }, { "source": "news", "source_name": "BBC News", "title": "Cardiff stun Scarlets with late URC fightback", "description": "Cardiff kept alive their United Rugby Championship (URC) play-off hopes with a dramatic bonus-point Welsh derby comeback win against Scarlets.", "url": "https://www.bbc.com/sport/rugby-union/articles/cd0rmy4dnn7o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-18", "published_at": "2026-04-18T18:49:46Z", "sentiment": { "label": "positive", "score": 0.931, "confidence": 0.93 } }, { "source": "news", "source_name": "BBC News", "title": "Cardiff stun Scarlets with late URC fightback", "description": "Cardiff kept alive their United Rugby Championship (URC) play-off hopes with a dramatic bonus-point Welsh derby comeback win against Scarlets.", "url": "https://www.bbc.com/sport/rugby-union/articles/cd0rmy4dnn7o", "date": "2026-04-18", "published_at": "2026-04-18T18:49:41Z", "sentiment": { "label": "positive", "score": 0.931, "confidence": 0.93 } }, { "source": "news", "source_name": "BBC News", "title": "Parsons hat-trick as Ireland thrash Italy in Galway", "description": "Beibhinn Parsons scores a hat-trick as Ireland turn on the style to thrash Italy in Galway and register their first Women's Six Nations win of the year.", "url": "https://www.bbc.com/sport/rugby-union/articles/cn0wvwddrdno?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-18", "published_at": "2026-04-18T18:43:15Z", "sentiment": { "label": "positive", "score": 0.586, "confidence": 0.59 } }, { "source": "news", "source_name": "BBC News", "title": "France cruise past Wales with second-half power show", "description": "France slip to second in the Six Nations table on points difference despite cruising to a 38-7 victory in Cardiff.", "url": "https://www.bbc.com/sport/rugby-union/articles/ce8lmn27jjno", "date": "2026-04-18", "published_at": "2026-04-18T16:52:15Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "BBC News", "title": "England score 12 tries in huge win over Scotland", "description": "Dominant England spoil Scotland's record-breaking afternoon at Murrayfield with a 12-try win which keeps them on course for another Six Nations title.", "url": "https://www.bbc.com/sport/rugby-union/articles/cwyx0lv9le4o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-18", "published_at": "2026-04-18T14:34:25Z", "sentiment": { "label": "positive", "score": 0.872, "confidence": 0.87 } }, { "source": "news", "source_name": "BBC News", "title": "Connacht comeback stuns Stormers in Cape Town", "description": "Connacht impress as they score five tries in a 33-24 bonus-point win over the Stormers in their United Rugby Championship game at the DHL Stadium.", "url": "https://www.bbc.com/sport/rugby-union/articles/c4gxyw79wnpo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-18", "published_at": "2026-04-18T14:11:18Z", "sentiment": { "label": "positive", "score": 0.91, "confidence": 0.91 } }, { "source": "news", "source_name": "BBC News", "title": "Connacht comeback stuns Stormers in Cape Town", "description": "Connacht impress as they score five tries in a 33-24 bonus-point win over the Stormers in their United Rugby Championship game at the DHL Stadium.", "url": "https://www.bbc.com/sport/rugby-union/articles/c4gxyw79wnpo", "date": "2026-04-18", "published_at": "2026-04-18T14:08:56Z", "sentiment": { "label": "positive", "score": 0.91, "confidence": 0.91 } }, { "source": "news", "source_name": "Decrypt", "title": "OpenAI's New AI Model Rosalind Could Shave Years Off Drug Discovery. You Probably Can't Use It", "description": "GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.", "url": "https://decrypt.co/364783/openai-gpt-rosalind-drug-discovery-life-sciences-model", "date": "2026-04-18", "published_at": "2026-04-18T13:01:03Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "BBC News", "title": "Bulls power past Dragons to boost URC play-offs bid", "description": "Play-off hopefuls Bulls climb to fifth in the United Rugby Championship by beating Dragons 47-7 in Newport.", "url": "https://www.bbc.com/sport/rugby-union/articles/cvgkky9707eo", "date": "2026-04-17", "published_at": "2026-04-17T20:39:53Z", "sentiment": { "label": "positive", "score": 0.66, "confidence": 0.66 } }, { "source": "news", "source_name": "IPWatchdog.com", "title": "Other Barks & Bites for Friday, April 17: CAFC Reverses District Court Rulings in Penile Implant Patent Case; CJEU Clarifies Scope of ‘Pastiche’ Copyright Exception; Stanford AI Index Shows Tech Gap Between U.S. And China Nearly Gone", "description": "This week in Other Barks & Bites: the Federal Circuit reverses a California district court’s denial of JMOL on trade secret and patent inventorship claims related to a cosmetic penile implant; the Senate Commerce Committee unanimously advances a bill to reaut…", "url": "https://ipwatchdog.com/?p=200592", "date": "2026-04-17", "published_at": "2026-04-17T17:30:18Z", "sentiment": { "label": "positive", "score": 0.226, "confidence": 0.23 } }, { "source": "pubmed", "pmid": "42034110", "title": "Effectiveness and persistence of biological and targeted synthetic treatment in patients with rheumatoid arthritis and chronic kidney disease: a multicentre, prospective cohort study.", "authors": "Fukui S et al.", "journal": "The Lancet. Rheumatology", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42034110/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42033786", "title": "OBC: Optimized Batch Correction with Dual-level Quality Control for Scalable Proteomics and Metabolomics.", "authors": "Zheng H et al.", "journal": "Genomics, proteomics & bioinformatics", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42033786/", "sentiment": { "label": "positive", "score": 0.459, "confidence": 0.46 } }, { "source": "pubmed", "pmid": "42032012", "title": "Real-world platinum selection in immune checkpoint inhibitor-based therapy for recurrent or metastatic head and neck cancer: an exploratory multi-institutional retrospective study.", "authors": "Yoshida J et al.", "journal": "Scientific reports", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42032012/", "sentiment": { "label": "negative", "score": -0.494, "confidence": 0.49 } }, { "source": "pubmed", "pmid": "42030522", "title": "Best Practices in GC-MS and GC × GC-MS-Based Metabolomics and Volatile Analyses: An International Survey.", "authors": "Giebelhaus RT et al.", "journal": "Analytical chemistry", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42030522/", "sentiment": { "label": "positive", "score": 0.637, "confidence": 0.64 } }, { "source": "pubmed", "pmid": "42029864", "title": "Introducing the J-CONNECT database: a real-world oncology resource for Japan.", "authors": "Okada M et al.", "journal": "International journal of clinical oncology", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42029864/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42028244", "title": "The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA(2)LEN ADCARE statement paper.", "authors": "Zuberbier T et al.", "journal": "The World Allergy Organization journal", "date": "2026-04-26", "url": "https://pubmed.ncbi.nlm.nih.gov/42028244/", "sentiment": { "label": "negative", "score": -0.402, "confidence": 0.4 } }, { "source": "pubmed", "pmid": "42024373", "title": "Identifying High-Risk Smoldering Multiple Myeloma for Early Intervention.", "authors": "Maeng CV et al.", "journal": "JAMA oncology", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42024373/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42021396", "title": "Mapping of pediatric allergy structures in Italy: a nationwide survey.", "authors": "Dinardo G et al.", "journal": "Italian journal of pediatrics", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42021396/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42018767", "title": "Heritability of Crohn's disease and ulcerative colitis: a Swedish nationwide population-based twin study.", "authors": "Grännö O et al.", "journal": "Journal of Crohn's & colitis", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/42018767/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42014032", "title": "Testing for hydroxyzine in human hair after a single controlled administration: First quantitative data.", "authors": "Arbouche N et al.", "journal": "Therapeutic drug monitoring", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42014032/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42013562", "title": "Immune-related gene expression profiling and alectinib efficacy for patients with ALK-Rearranged non-small cell lung cancer: exploratory analysis of a prospective observational study.", "authors": "Kurosaki T et al.", "journal": "Lung cancer (Amsterdam, Netherlands)", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/42013562/", "sentiment": { "label": "negative", "score": -0.66, "confidence": 0.66 } }, { "source": "pubmed", "pmid": "42013435", "title": "Development of a continuous-flow GC-IRMS method for the simultaneous determination of CO(2) concentration and isotopic composition (δ(13)C(CO2)) in volcanic and geothermal gases.", "authors": "Misseri M et al.", "journal": "Isotopes in environmental and health studies", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42013435/", "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "pubmed", "pmid": "42011740", "title": "Fragmentation Pathways and Enhanced Detection Sensitivity of OH-PBDEs via LC-ESI-MS(2): A Comprehensive Analytical Investigation.", "authors": "Fu B et al.", "journal": "Analytical chemistry", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42011740/", "sentiment": { "label": "neutral", "score": 0.05, "confidence": 0.05 } }, { "source": "pubmed", "pmid": "42010117", "title": "Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial.", "authors": "Nadeem O et al.", "journal": "Nature medicine", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42010117/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42008514", "title": "Diagnostic validation of a novel high-sensitivity cardiac troponin T assay.", "authors": "Völschow B et al.", "journal": "European heart journal. Acute cardiovascular care", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/42008514/", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "pubmed", "pmid": "42007733", "title": "Recommendations for HLA Genotyping Data Standards and Clinical Laboratory Staffing Considerations.", "authors": "Spierings E et al.", "journal": "HLA", "date": "2026-04-26", "url": "https://pubmed.ncbi.nlm.nih.gov/42007733/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "42001640", "title": "Evaluation of sampling and DNA extraction strategies for touch DNA recovery from plastic folder, wooden table, and plastic bag surfaces.", "authors": "Ünsal Sapan T et al.", "journal": "Journal of forensic and legal medicine", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/42001640/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41999962", "title": "Evolution of patient characteristics and outcomes in ATTR-CM clinical trials: A systematic review.", "authors": "Masri A et al.", "journal": "Progress in cardiovascular diseases", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41999962/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41999559", "title": "Exploring US patient and caregiver perspectives on burden associated with Friedreich Ataxia.", "authors": "Lawson R et al.", "journal": "Journal of patient-reported outcomes", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41999559/", "sentiment": { "label": "negative", "score": -0.44, "confidence": 0.44 } }, { "source": "pubmed", "pmid": "41998286", "title": "SLC33A1 exports oxidized glutathione to maintain endoplasmic reticulum redox homeostasis.", "authors": "Liu S et al.", "journal": "Nature cell biology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41998286/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41997165", "title": "Signe de cils in peripheral facial palsy.", "authors": "Oancea A et al.", "journal": "Lancet (London, England)", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41997165/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41996931", "title": "Esophageal papillomas and human papillomavirus infection: A case series, scoping review and analysis.", "authors": "Egg M et al.", "journal": "Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41996931/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41996733", "title": "Preparation method for in situ tensile testing in transmission electron microscopy based on push-to-pull chip.", "authors": "Huang R et al.", "journal": "Ultramicroscopy", "date": "2026 Apr 5", "url": "https://pubmed.ncbi.nlm.nih.gov/41996733/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41996200", "title": "Native Top-Down Mass Spectrometry Combined with High-Resolution Charge Variant Analysis of Trastuzumab Originator and Biosimilars.", "authors": "Beaumal C et al.", "journal": "Journal of the American Society for Mass Spectrometry", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41996200/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41996158", "title": "Quantitative Host Cell Protein Analysis of Antibody-Based Protein Therapeutics Using the Orbitrap Astral Mass Spectrometer.", "authors": "Smith J et al.", "journal": "Journal of the American Society for Mass Spectrometry", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41996158/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41993889", "title": "Tackling Neutrophilic Inflammation in Bronchiectasis: From Macrolides to Cathepsin C Inhibitors.", "authors": "Gramegna A et al.", "journal": "Journal of inflammation research", "date": "2026-04-26", "url": "https://pubmed.ncbi.nlm.nih.gov/41993889/", "sentiment": { "label": "negative", "score": -0.25, "confidence": 0.25 } }, { "source": "pubmed", "pmid": "41991782", "title": "Experiences of Migraine and Erenumab Treatment in Japan: Qualitative Interviews with Clinical Trial Participants.", "authors": "Dias-Barbosa C et al.", "journal": "The patient", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41991782/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41989977", "title": "Clusters of Invasive Haemophilus influenzae Type b Disease Among Adults Using Substances or Experiencing Homelessness or Housing Instability - Alaska, Oregon, and Washington, 2023─2025.", "authors": "Collins JP et al.", "journal": "MMWR. Morbidity and mortality weekly report", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41989977/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41986708", "title": "Molecular basis for methylation-sensitive editing by Cas9.", "authors": "Roth MO et al.", "journal": "Nature", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41986708/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41984154", "title": "Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry.", "authors": "Yildirim M et al.", "journal": "Clinical research in cardiology : official journal of the German Cardiac Society", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41984154/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41979819", "title": "Sexual Dysfunction with Antipsychotics: Emerging Clues from a Disproportionality Analysis of the World Health Organization VigiBase.", "authors": "Pavlidis E et al.", "journal": "Drug safety", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41979819/", "sentiment": { "label": "negative", "score": -0.421, "confidence": 0.42 } }, { "source": "pubmed", "pmid": "41972211", "title": "Electroencephalography during acute painful procedures in neonates: a scoping review.", "authors": "Gunawan PY et al.", "journal": "Pain reports", "date": "2026-04-26", "url": "https://pubmed.ncbi.nlm.nih.gov/41972211/", "sentiment": { "label": "negative", "score": -0.44, "confidence": 0.44 } }, { "source": "pubmed", "pmid": "41967561", "title": "Pre-analytic error and possible misinterpretation for macrotroponin.", "authors": "Kavsak PA et al.", "journal": "Clinical biochemistry", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41967561/", "sentiment": { "label": "negative", "score": -0.402, "confidence": 0.4 } }, { "source": "pubmed", "pmid": "41966763", "title": "IgE And IgG Antibody Responses to α-Gal and Association With Carotid Stenosis in Swedish Patients.", "authors": "Perusko M et al.", "journal": "Allergy", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41966763/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41965847", "title": "Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study.", "authors": "Palmason R et al.", "journal": "Blood cancer journal", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41965847/", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "pubmed", "pmid": "41965748", "title": "Experimental and computational methods for allelic imbalance analysis from single-nucleus RNA-seq data.", "authors": "Simmons SK et al.", "journal": "Genome biology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41965748/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41963505", "title": "The role of the molecular tumor board: learnings from the ROME trial.", "authors": "Marchetti P et al.", "journal": "NPJ precision oncology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41963505/", "sentiment": { "label": "negative", "score": -0.382, "confidence": 0.38 } }, { "source": "pubmed", "pmid": "41962871", "title": "An adaptive quantification scheme for profiling serum antibody level in transplant immunology.", "authors": "Schacker T et al.", "journal": "Transplant immunology", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41962871/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41960723", "title": "Treatment choice for chronic lymphocytic leukemia after covalent BTKi therapy: a patient and oncologist preference study.", "authors": "Michaels-Igbokwe C et al.", "journal": "Leukemia & lymphoma", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41960723/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41960557", "title": "Clinical phenotypes and molecular endotypes of chronic urticaria: Linking clinical expression to underlying immune mechanisms.", "authors": "Türk M et al.", "journal": "Asia Pacific allergy", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41960557/", "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "pubmed", "pmid": "41959400", "title": "Carafe2 enables high quality in silico spectral library generation for timsTOF data-independent acquisition proteomics.", "authors": "Wen B et al.", "journal": "bioRxiv : the preprint server for biology", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41959400/", "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "pubmed", "pmid": "41959335", "title": "Tumor-immune trajectory context connects static tissue architecture to clinical outcomes.", "authors": "Cramer EM et al.", "journal": "bioRxiv : the preprint server for biology", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41959335/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41959136", "title": "Serum proteomics reveals distinct phenotypic signatures to IL-6 blockade between two immunotherapies.", "authors": "Sniezek C et al.", "journal": "bioRxiv : the preprint server for biology", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41959136/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41957135", "title": "Impact of tumor location on the efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.", "authors": "Ozawa Y et al.", "journal": "British journal of cancer", "date": "2026 Apr 9", "url": "https://pubmed.ncbi.nlm.nih.gov/41957135/", "sentiment": { "label": "negative", "score": -0.718, "confidence": 0.72 } }, { "source": "pubmed", "pmid": "41951782", "title": "Reproductive hormone stability with prolonged intranasal oxytocin in adults with obesity.", "authors": "Galbiati F et al.", "journal": "International journal of obesity (2005)", "date": "2026 Apr 9", "url": "https://pubmed.ncbi.nlm.nih.gov/41951782/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41951141", "title": "Expanding the Global Map of Protein Post Translational Modifications with Immunoaffinity Enrichment and nDIA Analysis on the Orbitrap Astral Mass Spectrometer.", "authors": "Kumar M et al.", "journal": "Molecular & cellular proteomics : MCP", "date": "2026 Apr 6", "url": "https://pubmed.ncbi.nlm.nih.gov/41951141/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41950525", "title": "Toward Molecular Forensics of Agrochemicals with Orbitrap IRMS: Isotopic Fingerprints of Imidacloprid Sources and Elucidating Hydrolysis.", "authors": "Niemann F et al.", "journal": "Journal of the American Society for Mass Spectrometry", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41950525/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41950519", "title": "Cross-Sectional Imaging of the WS(2) Nanotube Formation Pathways.", "authors": "Bukvisova K et al.", "journal": "Nano letters", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41950519/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41947768", "title": "First 20 Years of Orbitrap Mass Spectrometry as the Mainstream Analytical Technique.", "authors": "Makarov A", "journal": "Mass spectrometry reviews", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41947768/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41938080", "title": "Clinical Concordance of Pan Lung Cancer PCR Panel Covering 167 Actionable Variants Across 11 Genes and Other Validated Assays in the LC-SCRUM-Asia Registry.", "authors": "Matsumoto S et al.", "journal": "JTO clinical and research reports", "date": "2026-04-26", "url": "https://pubmed.ncbi.nlm.nih.gov/41938080/", "sentiment": { "label": "negative", "score": -0.542, "confidence": 0.54 } } ] } }